Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Steven Haffner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Risk Factors

Living Beings

Chemicals & Drugs

Geographic Areas

Texas
Mexico

Procedures

Glucose Tolerance Test

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
183
Stern, Michael
85
Hazuda, Helen
63
Mitchell, Braxton
46
Mykkänen, Leena
40
Wagenknecht, Lynne
37
Saad, Mohammed
36
Williams, Ken
29
Festa, Andreas
27
D'Agostino, Ralph
24
Hanley, Anthony
22
Norris, Jill
20
Langefeld, Carl
20
D'Agostino, Ralph
19
Rewers, Marian
17
Bergman, Richard

Sign-in to see all Coauthors

Publications

TOP 3
Lorenzo Carlos; Aung KoKo; Stern Michael P; Haffner Steven M
Pulse pressure, prehypertension, and mortality: the San Antonio heart study.
Lorenzo Carlos; Williams Ken; Stern Michael P; Haffner Steven M
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.
Hanley A J G; Wagenknecht L E; Norris J M; Bryer-Ash M; Chen Y I; Anderson A M; Bergman R; Haffner S M
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Steven Haffner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lorenzo Carlos; Aung KoKo; Stern Michael P; Haffner Steven M
Pulse pressure, prehypertension, and mortality: the San Antonio heart study.
American journal of hypertension 2009;22(11):1219-26.
2009: Lorenzo Carlos; Williams Ken; Stern Michael P; Haffner Steven M
Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.
Metabolism: clinical and experimental 2009;58(11):1530-5.
2009: Hanley A J G; Wagenknecht L E; Norris J M; Bryer-Ash M; Chen Y I; Anderson A M; Bergman R; Haffner S M
Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.
Diabetologia 2009;52(10):2079-86.
2009: Mullican David R; Lorenzo Carlos; Haffner Steven M
Is prehypertension a risk factor for the development of type 2 diabetes?
Diabetes care 2009;32(10):1870-2.
2009: Norris Jill M; Langefeld Carl D; Talbert Matthew E; Wing Maria R; Haritunians Talin; Fingerlin Tasha E; Hanley Anthony J G; Ziegler Julie T; Taylor Kent D; Haffner Steven M; Chen Yii-Der I; Bowden Donald W; Wagenknecht Lynne E
Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family Study.
Obesity (Silver Spring, Md.) 2009;17(10):1932-41.
2009: Young Kendra A; Engelman Corinne D; Langefeld Carl D; Hairston Kristen G; Haffner Steven M; Bryer-Ash Michael; Norris Jill M
Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.
The Journal of clinical endocrinology and metabolism 2009;94(9):3306-13.
2009: Hairston Kristen G; Scherzinger Ann; Foy Capri; Hanley Anthony J; McCorkle Orita; Haffner Steven; Norris Jill M; Bryer-Ash Michael; Wagenknecht Lynne E
Five-year change in visceral adipose tissue quantity in a minority cohort: the Insulin Resistance Atherosclerosis Study (IRAS) family study.
Diabetes care 2009;32(8):1553-5.
2009: Liese Angela D; Nichols Michele; Sun Xuezheng; D'Agostino Ralph B; Haffner Steven M
Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes care 2009;32(8):1434-6.
2009: Schmitz Kimberly J; Skinner Halcyon G; Bautista Leonelo E; Fingerlin Tasha E; Langefeld Carl D; Hicks Pamela J; Haffner Steven M; Bryer-Ash Michael; Wagenknecht Lynne E; Bowden Donald W; Norris Jill M; Engelman Corinne D
Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans.
American journal of hypertension 2009;22(8):867-70.
2009: Talbert Matthew E; Langefeld Carl D; Ziegler Julie T; Haffner Steven M; Norris Jill M; Bowden Donald W
INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.
Obesity (Silver Spring, Md.) 2009;17(8):1554-62.
2009: Parving Hans-Henrik; Brenner Barry M; McMurray John J V; de Zeeuw Dick; Haffner Steven M; Solomon Scott D; Chaturvedi Nish; Pfeffer Marc A
Dual renin-angiotensin system blockade and kidney disease.
Journal of the American College of Cardiology 2009;54(3):278-9; author reply 279-80.
2009: Rich S S; Goodarzi M O; Palmer N D; Langefeld C D; Ziegler J; Haffner S M; Bryer-Ash M; Norris J M; Taylor K D; Haritunians T; Rotter J I; Chen Y-D I; Wagenknecht L E; Bowden D W; Bergman R N
A genome-wide association scan for acute insulin response to glucose in Hispanic-Americans: the Insulin Resistance Atherosclerosis Family Study (IRAS FS).
Diabetologia 2009;52(7):1326-33.
2009: Lorenzo C; Nath S D; Hanley A J G; Abboud H E; Gelfond J A L; Haffner S M
Risk of type 2 diabetes among individuals with high and low glomerular filtration rates.
Diabetologia 2009;52(7):1290-7.
2009: Wagenknecht Lynne E; Scherzinger Ann L; Stamm Elizabeth R; Hanley Anthony J G; Norris Jill M; Chen Yii-Der I; Bryer-Ash Michael; Haffner Steven M; Rotter Jerome I
Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.
Obesity (Silver Spring, Md.) 2009;17(6):1240-6.
2009: Sutton Beth S; Palmer Nicholette D; Langefeld Carl D; Xue Bingzhong; Proctor Alexandria; Ziegler Julie T; Haffner Steven M; Norris Jill M; Bowden Donald W
Association of SSTR2 polymorphisms and glucose homeostasis phenotypes: the Insulin Resistance Atherosclerosis Family Study.
Diabetes 2009;58(6):1457-62.
2009: Wing Maria R; Ziegler Julie; Langefeld Carl D; Ng Maggie C Y; Haffner Steven M; Norris Jill M; Goodarzi Mark O; Bowden Donald W
Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.
Human genetics 2009;125(5-6):615-26.
2009: Dasgupta Arijit; Steinhubl Steven R; Bhatt Deepak L; Berger Peter B; Shao Mingyuan; Mak Koon-Hou; Fox Keith A A; Montalescot Gilles; Weber Michael A; Haffner Steven M; Dimas Alexios P; Steg P Gabriel; Topol Eric J;
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
The American journal of cardiology 2009;103(10):1359-63.
2009: Beihl Deborah A; Liese Angela D; Haffner Steven M
Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort.
Annals of epidemiology 2009;19(5):351-7.
2009: Sam Susan; Haffner Steven; Davidson Michael H; D'Agostino Ralph B; Feinstein Steven; Kondos George; Perez Alfonso; Mazzone Theodore
Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes.
Diabetes care 2009;32(5):932-7.
2009: Stancáková Alena; Javorský Martin; Kuulasmaa Teemu; Haffner Steven M; Kuusisto Johanna; Laakso Markku
Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men.
Diabetes 2009;58(5):1212-21.
2009: MacKay Meredith F; Haffner Steven M; Wagenknecht Lynne E; D'Agostino Ralph B; Hanley Anthony J G
Prediction of type 2 diabetes using alternate anthropometric measures in a multi-ethnic cohort: the insulin resistance atherosclerosis study.
Diabetes care 2009;32(5):956-8.
2009: Parving Hans-Henrik; Brenner Barry M; McMurray John J V; de Zeeuw Dick; Haffner Steven M; Solomon Scott D; Chaturvedi Nish; Ghadanfar Mathieu; Weissbach Nicole; Xiang Zhihua; Armbrecht Juergen; Pfeffer Marc A
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(5):1663-71.
2009: Mak Koon-Hou; Bhatt Deepak L; Shao Mingyuan; Haffner Steven M; Hamm Christian W; Hankey Graeme J; Johnston S Claiborne; Montalescot Gilles; Steg Philippe Gabriel; Steinhubl Steven R; Fox Keith A A; Topol Eric J
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
European heart journal 2009;30(7):857-65.
2009: Goldberg Ronald B; Temprosa Marinella; Haffner Steven; Orchard Trevor J; Ratner Robert E; Fowler Sarah E; Mather Kieren; Marcovina Santica; Saudek Chris; Matulik Margaret J; Price David;
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
Diabetes care 2009;32(4):726-32.
2009: Talbert Matthew E; Langefeld Carl D; Ziegler Julie; Mychaleckyj Josyf C; Haffner Steven M; Norris Jill M; Bowden Donald W
Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.
Human genetics 2009;125(2):153-62.
2009: McGill Janet B; Haffner Steven; Rees Tomas J; Sowers James R; Tershakovec Andrew M; Weber Michael
Progress and controversies: treating obesity and insulin resistance in the context of hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(1):36-41.
2008: Zappe Dion H; Sowers James R; Hsueh Willa A; Haffner Steven M; Deedwania Prakash C; Fonseca Vivian A; Keeling Lucy; Sica Domenic A
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(12):894-903.
2008: Williams Ken; Tchernof Andre; Hunt Kelly J; Wagenknecht Lynne E; Haffner Steven M; Sniderman Allan D
Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men.
Diabetes 2008;57(12):3289-96.
2008: Califf Robert M; Boolell Mitradev; Haffner Steven M; Bethel M Angelyn; McMurray John; Duggal Anil; Holman Rury R;
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
American heart journal 2008;156(4):623-32.
2008: Bethel M Angelyn; Holman Rury; Haffner Steven M; Califf Robert M; Huntsman-Labed Alice; Hua Tsushung A; McMurray John
Determining the most appropriate components for a composite clinical trial outcome.
American heart journal 2008;156(4):633-40.
2008: Rosenzweig James L; Ferrannini Ele; Grundy Scott M; Haffner Steven M; Heine Robert J; Horton Edward S; Kawamori Ryuzo;
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2008;93(10):3671-89.
2008: Espeland Mark A; Regensteiner Judith G; Jaramillo Sarah A; Gregg Edward; Knowler William C; Wagenknecht Lynne E; Bahnson Judy; Haffner Steven; Hill James; Hiatt William R;
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study.
Vascular medicine (London, England) 2008;13(3):225-33.
2008: Foy Capri G; Hsu Fang-Chi; Haffner Steven M; Norris Jill M; Rotter Jerome I; Henkin Leora F; Bryer-Ash Michael; Chen Yii-Der I; Wagenknecht Lynne E
Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.
American journal of hypertension 2008;21(8):910-6.
2008: Sam Susan; Haffner Steven; Davidson Michael H; D'Agostino Ralph B; Feinstein Steven; Kondos George; Perez Alfonso; Mazzone Theodore
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
Diabetes 2008;57(8):2022-7.
2008: Grunfeld Carl; Kotler Donald P; Arnett Donna K; Falutz Julian M; Haffner Steven M; Hruz Paul; Masur Henry; Meigs James B; Mulligan Kathleen; Reiss Peter; Samaras Katherine;
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.
Circulation 2008;118(2):e20-8.
2008: Crandall Jill P; Knowler William C; Kahn Steven E; Marrero David; Florez Jose C; Bray George A; Haffner Steven M; Hoskin Mary; Nathan David M;
The prevention of type 2 diabetes.
Nature clinical practice. Endocrinology & metabolism 2008;4(7):382-93.
2008: Festa Andreas; Williams Ken; Hanley Anthony J G; Haffner Steven M
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Diabetes 2008;57(6):1638-44.
2008: Bray George A; Jablonski Kathleen A; Fujimoto Wilfred Y; Barrett-Connor Elizabeth; Haffner Steven; Hanson Robert L; Hill James O; Hubbard Van; Kriska Andrea; Stamm Elizabeth; Pi-Sunyer F Xavier;
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.
The American journal of clinical nutrition 2008;87(5):1212-8.
2008: Lorenzo Carlos; Nath Subrata D; Hanley Anthony J G; Abboud Hanna E; Haffner Steven M
Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(3):783-9.
2008: Kahn Steven E; Zinman Bernard; Lachin John M; Haffner Steven M; Herman William H; Holman Rury R; Kravitz Barbara G; Yu Dahong; Heise Mark A; Aftring R Paul; Viberti Giancarlo;
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Diabetes care 2008;31(5):845-51.
2008: Davidson Michael; Meyer Peter M; Haffner Steven; Feinstein Steven; D'Agostino Ralph; Kondos George T; Perez Alfonso; Chen Zhen; Mazzone Theodore
Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Circulation 2008;117(16):2123-30.
2008: Palmer Nicholette D; Goodarzi Mark O; Langefeld Carl D; Ziegler Julie; Norris Jill M; Haffner Steven M; Bryer-Ash Michael; Bergman Richard N; Wagenknecht Lynne E; Taylor Kent D; Rotter Jerome I; Bowden Donald W
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
Diabetes 2008;57(4):1093-100.
2008: Black Mary Helen; Fingerlin Tasha E; Allayee Hooman; Zhang Weiming; Xiang Anny H; Trigo Enrique; Hartiala Jaana; Lehtinen Allison B; Haffner Steven M; Bergman Richard N; McEachin Richard C; Kjos Siri L; Lawrence Jean M; Buchanan Thomas A; Watanabe Richard M
Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans.
Diabetes 2008;57(4):1048-56.
2008: Rubin Richard R; Ma Yong; Marrero David G; Peyrot Mark; Barrett-Connor Elizabeth L; Kahn Steven E; Haffner Steven M; Price David W; Knowler William C;
Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.
Diabetes care 2008;31(3):420-6.
2008: Bertoni Alain G; Clark Jeanne M; Feeney Patricia; Yanovski Susan Z; Bantle John; Montgomery Brenda; Safford Monika M; Herman William H; Haffner Steven;
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
Journal of diabetes and its complications 2008;22(1):1-9.
2008: Palmer Nicholette D; Lehtinen Allison B; Langefeld Carl D; Campbell Joel K; Haffner Steven M; Norris Jill M; Bergman Richard N; Goodarzi Mark O; Rotter Jerome I; Bowden Donald W
Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans.
The Journal of clinical endocrinology and metabolism 2008;93(1):304-9.
2007: Rose David P; Haffner Steven M; Baillargeon Jacques
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.
Endocrine reviews 2007;28(7):763-77.
2007: Grunfeld Carl; Rimland David; Gibert Cynthia L; Powderly William G; Sidney Stephen; Shlipak Michael G; Bacchetti Peter; Scherzer Rebecca; Haffner Steven; Heymsfield Steven B
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):283-90.
2007: Hunt Kelly J; Williams Ken; Hazuda Helen P; Stern Michael P; Haffner Steve M
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.
Annals of epidemiology 2007;17(11):870-7.
2007: Balkau Beverley; Deanfield John E; Després Jean-Pierre; Bassand Jean-Pierre; Fox Keith A A; Smith Sidney C; Barter Philip; Tan Chee-Eng; Van Gaal Luc; Wittchen Hans-Ulrich; Massien Christine; Haffner Steven M
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.
Circulation 2007;116(17):1942-51.
2007: Femia Romana; Kozakova Michaela; Nannipieri Monica; Gonzales-Villalpando Clicerio; Stern Michael P; Haffner Steven M; Ferrannini Ele
Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2244-9.
2007: Herman William H; Ma Yong; Uwaifo Gabriel; Haffner Steven; Kahn Steven E; Horton Edward S; Lachin John M; Montez Maria G; Brenneman Tina; Barrett-Connor Elizabeth;
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.
Diabetes care 2007;30(10):2453-7.
2007: Haffner Steven M
Abdominal adiposity and cardiometabolic risk: do we have all the answers?
The American journal of medicine 2007;120(9 Suppl 1):S10-6; discussion S16-7.
2007: Lorenzo Carlos; Serrano-Ríos Manuel; Martínez-Larrad María T; González-Villalpando Clicerio; González-Sánchez José L; Martínez-Calatrava María J; Gabriel Rafael; Haffner Steven M
Is waist circumference an essential component of the metabolic syndrome?
Diabetes care 2007;30(8):2141-2.
2007: Olijhoek Jobien K; van der Graaf Yolanda; Haffner Steven M; Visseren Frank L J;
Defining the metabolic syndrome: Resolving unresolved issues?
European journal of internal medicine 2007;18(4):309-13.
2007: Hanley Anthony J G; Wagenknecht Lynne E; Festa Andreas; D'Agostino Ralph B; Haffner Steven M
Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Diabetes care 2007;30(7):1819-27.
2007: Hanley Anthony J G; Bowden Donald; Wagenknecht Lynne E; Balasubramanyam Aarthi; Langfeld Carl; Saad Mohammed F; Rotter Jerome I; Guo Xiuqing; Chen Yii-Der I; Bryer-Ash Michael; Norris Jill M; Haffner Steven M
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans.
The Journal of clinical endocrinology and metabolism 2007;92(7):2665-71.
2007: Pi-Sunyer Xavier; Blackburn George; Brancati Frederick L; Bray George A; Bright Renee; Clark Jeanne M; Curtis Jeffrey M; Espeland Mark A; Foreyt John P; Graves Kathryn; Haffner Steven M; Harrison Barbara; Hill James O; Horton Edward S; Jakicic John; Jeffery Robert W; Johnson Karen C; Kahn Steven; Kelley David E; Kitabchi Abbas E; Knowler William C; Lewis Cora E; Maschak-Carey Barbara J; Montgomery Brenda; Nathan David M; Patricio Jennifer; Peters Anne; Redmon J Bruce; Reeves Rebecca S; Ryan Donna H; Safford Monika; Van Dorsten Brent; Wadden Thomas A; Wagenknecht Lynne; Wesche-Thobaben Jacqueline; Wing Rena R; Yanovski Susan Z
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.
Diabetes care 2007;30(6):1374-83.
2007: Fujimoto Wilfred Y; Jablonski Kathleen A; Bray George A; Kriska Andrea; Barrett-Connor Elizabeth; Haffner Steven; Hanson Robert; Hill James O; Hubbard Van; Stamm E; Pi-Sunyer F Xavier;
Body size and shape changes and the risk of diabetes in the diabetes prevention program.
Diabetes 2007;56(6):1680-5.
2007: Lorenzo Carlos; Serrano-Ríos Manuel; Martínez-Larrad María T; Gonzalez-Villalpando Clicerio; Williams Ken; Gabriel Rafael; Stern Michael P; Haffner Steven M
Which obesity index best explains prevalence differences in type 2 diabetes mellitus?
Obesity (Silver Spring, Md.) 2007;15(5):1294-301.
2007: Sedjo Rebecca L; Byers Tim; Levin Theodore R; Haffner Steven M; Saad Mohammed F; Tooze Janet A; D'Agostino Ralph B
Change in body size and the risk of colorectal adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):526-31.
2007: Mazzone Theodore; Meyer Peter M; Kondos George T; Davidson Michael H; Feinstein Steven B; D'Agostino Ralph B; Perez Alfonso; Haffner Steven M
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
Diabetes 2007;56(3):849-55.
2007: Lorenzo Carlos; Williams Ken; Hunt Kelly J; Haffner Steven M
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
Diabetes care 2007;30(1):8-13.
2007: Goodarzi Mark O; Taylor Kent D; Guo Xiuqing; Hokanson John E; Haffner Steven M; Cui Jinrui; Chen Yii-Der I; Wagenknecht Lynne E; Bergman Richard N; Rotter Jerome I
Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.
The Journal of clinical endocrinology and metabolism 2007;92(1):293-6.
2007: Haffner Steven M
Unmet needs in controlling metabolic disease.
Reviews in cardiovascular medicine 2007;8 Suppl 4():S17-24.
2006: Bray George; Gregg Edward; Haffner Steven; Pi-Sunyer Xavier F; WagenKnecht Lynne E; Walkup Michael; Wing Rena
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2006;3(3):202-15.
2006: Kahn Steven E; Haffner Steven M; Heise Mark A; Herman William H; Holman Rury R; Jones Nigel P; Kravitz Barbara G; Lachin John M; O'Neill M Colleen; Zinman Bernard; Viberti Giancarlo;
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
The New England journal of medicine 2006;355(23):2427-43.
2006: Viberti G; Lachin J; Holman R; Zinman B; Haffner S; Kravitz B; Heise M A; Jones N P; O'Neill M C; Freed M I; Kahn S E; Herman W H;
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(12):1289-94.
2006: Mazzone Theodore; Meyer Peter M; Feinstein Steven B; Davidson Michael H; Kondos George T; D'Agostino Ralph B; Perez Alfonso; Provost Jean-Claude; Haffner Steven M
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
JAMA : the journal of the American Medical Association 2006;296(21):2572-81.
2006: Deedwania Prakash; Barter Philip; Carmena Rafael; Fruchart Jean-Charles; Grundy Scott M; Haffner Steven; Kastelein John J P; LaRosa John C; Schachner Holly; Shepherd James; Waters David D;
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet 2006;368(9539):919-28.
2006: Lloret Ramon; Ycas Joseph; Stein Michael; Haffner Steven;
Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial).
The American journal of cardiology 2006;98(6):768-73.
2006: Sutton B S; Langefeld C D; Campbell J K; Haffner S M; Norris J M; Scherzinger A L; Wagenknecht L E; Bowden D W
Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study.
International journal of obesity (2005) 2006;30(9):1433-41.
2006: Kahn Steven E; Zinman Bernard; Haffner Steven M; O'Neill M Colleen; Kravitz Barbara G; Yu Dahong; Freed Martin I; Herman William H; Holman Rury R; Jones Nigel P; Lachin John M; Viberti Giancarlo C;
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Diabetes 2006;55(8):2357-64.
2006: Baillargeon Jacques; Platz Elizabeth A; Rose David P; Pollock Brad H; Ankerst Donna Pauler; Haffner Steven; Higgins Betsy; Lokshin Anna; Troyer Dean; Hernandez Javier; Lynch Steve; Leach Robin J; Thompson Ian M
Obesity, adipokines, and prostate cancer in a prospective population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(7):1331-5.
2006: Cassells Holly B; Haffner Steven M
The metabolic syndrome: risk factors and management.
The Journal of cardiovascular nursing 2006;21(4):306-13.
2006: Bersot Thomas; Haffner Steven; Harris William S; Kellick Kenneth A; Morris Charlene M
Hypertriglyceridemia: management of atherogenic dyslipidemia.
The Journal of family practice 2006;55(7):S1-8.
2006: Haffner Steven M
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Obesity (Silver Spring, Md.) 2006;14 Suppl 3():121S-127S.
2006: Shepherd James; Barter Philip; Carmena Rafael; Deedwania Prakash; Fruchart Jean-Charles; Haffner Steven; Hsia Judith; Breazna Andrei; LaRosa John; Grundy Scott; Waters David
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
Diabetes care 2006;29(6):1220-6.
2006: Kriska Andrea M; Edelstein Sharon L; Hamman Richard F; Otto Amy; Bray George A; Mayer-Davis Elizabeth J; Wing Rena R; Horton Edward S; Haffner Steven M; Regensteiner Judith G
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program.
Medicine and science in sports and exercise 2006;38(5):826-32.
2006: Haffner Steven M
Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
The American journal of medicine 2006;119(5 Suppl 1):S3-9.
2006: Festa Andreas; Williams Ken; Tracy Russell P; Wagenknecht Lynne E; Haffner Steven M
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
Circulation 2006;113(14):1753-9.
2006: Festa Andreas; Williams Ken; D'Agostino Ralph; Wagenknecht Lynne E; Haffner Steven M
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.
Diabetes 2006;55(4):1114-20.
2006: Bhatt Deepak L; Fox Keith A A; Hacke Werner; Berger Peter B; Black Henry R; Boden William E; Cacoub Patrice; Cohen Eric A; Creager Mark A; Easton J Donald; Flather Marcus D; Haffner Steven M; Hamm Christian W; Hankey Graeme J; Johnston S Claiborne; Mak Koon-Hou; Mas Jean-Louis; Montalescot Gilles; Pearson Thomas A; Steg P Gabriel; Steinhubl Steven R; Weber Michael A; Brennan Danielle M; Fabry-Ribaudo Liz; Booth Joan; Topol Eric J;
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
The New England journal of medicine 2006;354(16):1706-17.
2006: Haffner Steven
Diabetes and the metabolic syndrome--when is it best to intervene to prevent?
Atherosclerosis. Supplements 2006;7(1):3-10.
2006: Haffner Steve M; Ruilope Luis; Dahlöf Björn; Abadie Eric; Kupfer Stuart; Zannad Faiez
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials.
Journal of cardiovascular pharmacology 2006;47(3):469-75.
2006: Lorenzo Carlos; Serrano-Ríos Manuel; Martínez-Larrad María T; González-Sánchez José L; Seclén Segundo; Villena Arturo; Gonzalez-Villalpando Clicerio; Williams Ken; Haffner Steven M
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.
Diabetes care 2006;29(3):685-91.
2006: Lorenzo Carlos; Williams Ken; Hunt Kelly J; Haffner Steven M
Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.
Diabetes care 2006;29(3):625-30.
2006: Barter P J; Ballantyne C M; Carmena R; Castro Cabezas M; Chapman M John; Couture P; de Graaf J; Durrington P N; Faergeman O; Frohlich J; Furberg C D; Gagne C; Haffner S M; Humphries S E; Jungner I; Krauss R M; Kwiterovich P; Marcovina S; Packard C J; Pearson T A; Reddy K Srinath; Rosenson R; Sarrafzadegan N; Sniderman A D; Stalenhoef A F; Stein E; Talmud P J; Tonkin A M; Walldius G; Williams K M S
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Journal of internal medicine 2006;259(3):247-58.
2006: Haffner Steven M
The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.
The American journal of cardiology 2006;97(2A):3A-11A.
2006: Pladevall Manel; Singal Bonita; Williams L Keoki; Brotons Carlos; Guyer Heidi; Sadurni Josep; Falces Carles; Serrano-Rios Manuel; Gabriel Rafael; Shaw Jonathan E; Zimmet Paul Z; Haffner Steven
A single factor underlies the metabolic syndrome: a confirmatory factor analysis.
Diabetes care 2006;29(1):113-22.
2005: Hanley Anthony J G; Karter Andrew J; Williams Ken; Festa Andreas; D'Agostino Ralph B; Wagenknecht Lynne E; Haffner Steven M
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Circulation 2005;112(24):3713-21.
2005: Hanley Anthony J G; Williams Ken; Festa Andreas; Wagenknecht Lynne E; D'Agostino Ralph B; Haffner Steven M
Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Diabetes 2005;54(11):3140-7.
2005: Lorenzo Carlos; Williams Ken; Gonzalez-Villalpando Clicerio; Haffner Steven M
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity.
Diabetes care 2005;28(10):2480-5.
2005: Sutton Beth S; Langefeld Carl D; Williams Adrienne H; Norris Jill M; Saad Mohammed F; Haffner Steven M; Bowden Donald W
Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study.
Obesity research 2005;13(9):1491-8.
2005: Bhatt Deepak L; Fox Keith A; Hacke Werner; Berger Peter B; Black Henry R; Boden William E; Cacoub Patrice; Cohen Eric A; Creager Mark A; Easton J Donald; Flather Marcus D; Haffner Steven M; Hamm Christian W; Hankey Graeme J; Johnston S Claiborne; Mak Koon-Hou; Mas Jean-Louis; Montalescot Gilles; Pearson Thomas A; Steg P Gabriel; Steinhubl Steven R; Weber Michael A; Booth Joan; Topol Eric J;
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
American heart journal 2005;150(3):401.
2005: Haffner Steven
Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
The American journal of cardiology 2005;96(4A):33E-36E.
2005: Vauhkonen Ilkka; Niskanen Leo; Knip Mikael; Mykkänen Leena Moilanen; Haffner Steven; Uusitupa Matti; Laakso Markku
Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(2):265-73.
2005: Kitabchi Abbas E; Temprosa Marinella; Knowler William C; Kahn Steven E; Fowler Sarah E; Haffner Steven M; Andres Reuben; Saudek Christopher; Edelstein Sharon L; Arakaki Richard; Murphy Mary Beth; Shamoon Harry;
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Diabetes 2005;54(8):2404-14.
2005: Corona Aida Jimenez; Martinez David Rivera; Avila Mauricio Hernandez; Haffner Steven; Williams Ken; González Villalpando Maria Elena; Simon Jesus; Stern Michael; Gonzalez-Villalpando Clicerio
Microalbuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study.
Kidney international. Supplement 2005;(97):S34-9.
2005: Nannipieri Monica; Gonzales Clicerio; Baldi Simona; Posadas Rosalinda; Williams Ken; Haffner Steven M; Stern Michael P; Ferrannini Ele;
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Diabetes care 2005;28(7):1757-62.
2005: Sutton Beth S; Weinert Stefanie; Langefeld Carl D; Williams Adrienne H; Campbell Joel K; Saad Mohammed F; Haffner Steven M; Norris Jill M; Bowden Donald W
Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study.
Human genetics 2005;117(2-3):107-18.
2005: Libby Peter; Nathan David M; Abraham Kristin; Brunzell John D; Fradkin Judith E; Haffner Steven M; Hsueh Willa; Rewers Marian; Roberts B Tibor; Savage Peter J; Skarlatos Sonia; Wassef Momtaz; Rabadan-Diehl Cristina;
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.
Circulation 2005;111(25):3489-93.
2005: Festa Andreas; Williams Ken; Hanley Anthony J G; Otvos James D; Goff David C; Wagenknecht Lynne E; Haffner Steven M
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
Circulation 2005;111(25):3465-72.
2005: Karmally Wahida; Montez Maria G; Palmas Walter; Martinez Wendy; Branstetter Anita; Ramakrishnan Rajasekhar; Holleran Steve F; Haffner Steven M; Ginsberg Henry N
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
Journal of the American Dietetic Association 2005;105(6):967-70.
2005: Hanley Anthony J G; Meigs James B; Williams Ken; Haffner Steven M; D'Agostino Ralph B
Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome".
American journal of epidemiology 2005;161(12):1182-4.
2005: Guo Xiuqing; Cui Jinrui; Wagenknecht Lynne E; Norris Jill M; Haffner Steven M; Darwin Christine; Jinagouda Sujata; Rotter Jerome I; Saad Mohammed F
Cosegregation of albuminuria and blood pressure: the Insulin Resistance Atherosclerosis (IRAS) family study.
American journal of hypertension 2005;18(6):823-7.
2005: Festa Andreas; Haffner Steven M
Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.
Circulation 2005;111(19):2414-5.
2005: Haffner Steven; Temprosa Marinella; Crandall Jill; Fowler Sarah; Goldberg Ronald; Horton Edward; Marcovina Santica; Mather Kieren; Orchard Trevor; Ratner Robert; Barrett-Connor Elizabeth;
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.
Diabetes 2005;54(5):1566-72.
2005: Karter A J; D'Agostino R B; Mayer-Davis E J; Wagenknecht L E; Hanley A J G; Hamman R F; Bergman R; Saad M F; Haffner S M;
Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS).
Diabetes, obesity & metabolism 2005;7(3):230-8.
2005: Orchard Trevor J; Temprosa Marinella; Goldberg Ronald; Haffner Steven; Ratner Robert; Marcovina Santica; Fowler Sarah;
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Annals of internal medicine 2005;142(8):611-9.
2005: Ratner Robert; Goldberg Ronald; Haffner Steven; Marcovina Santica; Orchard Trevor; Fowler Sarah; Temprosa Marinella;
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Diabetes care 2005;28(4):888-94.
2005: Lorenzo Carlos; Williams Ken; Gonzalez-Villalpando Clicerio; Stern Michael P; Hazuda Helen P; Haffner Steven M
Lower hypertension risk in Mexico City than in San Antonio.
American journal of hypertension 2005;18(3):385-91.
2005: Davey Smith George; Bracha Yiscah; Svendsen Kenneth H; Neaton James D; Haffner Steven M; Kuller Lewis H;
Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Annals of internal medicine 2005;142(5):313-22.
2005: Goff David C; D'Agostino Ralph B; Haffner Steven M; Otvos James D
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
Metabolism: clinical and experimental 2005;54(2):264-70.
2005: Rich Stephen S; Bowden Donald W; Haffner Steven M; Norris Jill M; Saad Mohammed F; Mitchell Braxton D; Rotter Jerome I; Langefeld Carl D; Hedrick Catherine C; Wagenknecht Lynne E; Bergman Richard N;
A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study.
Diabetes 2005;54(1):290-5.
2005: Norris J M; Langefeld C D; Scherzinger A L; Rich S S; Bookman E; Beck S R; Saad M F; Haffner S M; Bergman R N; Bowden D W; Wagenknecht L E
Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study.
International journal of obesity (2005) 2005;29(1):67-77.
2005: Drexler Andrew J; Nesto Richard W; Abrahamson Martin J; Bakris George; Bell David; Brunzell John; Dandona Paresh; Davidson Jaime; Fonseca Vivian; Fowler Michael; Frye Robert; Giles Thomas; Haffner Steven; Hollenberg Norman; Hsueh Willa; Law Ronald; Plutzky Jorge; Ratner Robert; Reusch Jane; Selwyn Andrew; Sowers James; Wyne Kathleen; Young Lawrence H
Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome.
Metabolic syndrome and related disorders 2005;3(2):147-73.
2004: Zinman Bernard; Kahn Steven E; Haffner Steven M; O'Neill M Colleen; Heise Mark A; Freed Martin I;
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Diabetes 2004;53(12):3193-200.
2004: Stern Michael P; Williams Ken; González-Villalpando Clicerio; Hunt Kelly J; Haffner Steven M
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
Diabetes care 2004;27(11):2676-81.
2004: Sattar Naveed; Williams Ken; Sniderman Allan D; D'Agostino Ralph; Haffner Steven M
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
Circulation 2004;110(17):2687-93.
2004: Hanley Anthony J G; Williams Ken; Festa Andreas; Wagenknecht Lynne E; D'Agostino Ralph B; Kempf Judy; Zinman Bernard; Haffner Steven M;
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes 2004;53(10):2623-32.
2004: Haffner Steven M
Type 2 diabetes and the metabolic syndrome: national cholesterol education program guidelines and supporting evidence.
Critical pathways in cardiology 2004;3(3 Suppl):S12-4.
2004: D'Agostino Ralph B; Hamman Richard F; Karter Andrew J; Mykkanen Leena; Wagenknecht Lynne E; Haffner Steven M;
Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes care 2004;27(9):2234-40.
2004: Hunt Kelly J; Resendez Roy G; Williams Ken; Haffner Steve M; Stern Michael P;
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
Circulation 2004;110(10):1251-7.
2004: Rich Stephen S; Bowden Donald W; Haffner Steven M; Norris Jill M; Saad Mohammed F; Mitchell Braxton D; Rotter Jerome I; Langefeld Carl D; Wagenknecht Lynne E; Bergman Richard N;
Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
Diabetes 2004;53(7):1866-75.
2004: Hanley Anthony J G; Festa Andreas; D'Agostino Ralph B; Wagenknecht Lynne E; Savage Peter J; Tracy Russell P; Saad Mohammed F; Haffner Steven M
Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.
Diabetes 2004;53(7):1773-81.
2004: Meigs James B; Williams Ken; Sullivan Lisa M; Hunt Kelly J; Haffner Steven M; Stern Michael P; González Villalpando Clicerio; Perhanidis Jessica S; Nathan David M; D'Agostino Ralph B; D'Agostino Ralph B; Wilson Peter W F
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
Diabetes care 2004;27(6):1417-26.
2004: Festa Andreas; D'Agostino Ralph; Hanley Anthony J G; Karter Andrew J; Saad Mohammed F; Haffner Steven M
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
Diabetes 2004;53(6):1549-55.
2004: Saad Mohammed F; Rewers Marian; Selby Joseph; Howard George; Jinagouda Sujata; Fahmi Salwa; Zaccaro Dan; Bergman Richard N; Savage Peter J; Haffner Steven M
Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study.
Hypertension 2004;43(6):1324-31.
2004: Mitchell Braxton D; Zaccaro Daniel; Wagenknecht Lynne E; Scherzinger Ann L; Bergman Richard N; Haffner Steven M; Hokanson John; Norris Jill M; Rotter Jerome I; Saad Mohammed F
Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study.
Obesity research 2004;12(5):831-9.
2004: Kempen John H; O'Colmain Benita J; Leske M Cristina; Haffner Steven M; Klein Ronald; Moss Scot E; Taylor Hugh R; Hamman Richard F;
The prevalence of diabetic retinopathy among adults in the United States.
Archives of ophthalmology 2004;122(4):552-63.
2004: Rewers Marian; Zaccaro Daniel; D'Agostino Ralph; Haffner Steven; Saad Mohammed F; Selby Joe V; Bergman Richard; Savage Peter;
Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.
Diabetes care 2004;27(3):781-7.
2004: Feeman W E; Sattar Naveed; OReilly Denis St J; Packard Chris J; Shepherd James; Gaw Allan; Macfarlane Peter W; Cobbe Stuart M; Scherbakova Olga; Ford Ian; Haffner Steven M; Isles Chris
Metabolic syndrome and diabetes mellitus.
Circulation 2004;109(3):E23.
2004: Haffner Steven M;
Dyslipidemia management in adults with diabetes.
Diabetes care 2004;27 Suppl 1():S68-71.
2004: Bensen Jeannette T; Hsu Fang-Chi; Brown W Mark; Sutton Beth S; Norris Jill M; Tracy Russell P; Jenny Nancy S; Saad Mohammed F; Haffner Steven; Bowden Donald W; Langefeld Carl D
Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study.
Human heredity 2004;57(3):128-37.
2003: Lorenzo Carlos; Serrano-Ríos Manuel; Martínez-Larrad María T; Gabriel Rafael; Williams Ken; Gómez-Gerique Juan A; Stern Michael P; Haffner Steven M
Central adiposity determines prevalence differences of the metabolic syndrome.
Obesity research 2003;11(12):1480-7.
2003: Haffner Steven J; Cassells Holly
Hyperglycemia as a cardiovascular risk factor.
The American journal of medicine 2003;115 Suppl 8A():6S-11S.
2003: Snehalatha Chamukuttan; Mukesh Bheekamchand; Simon Mary; Viswanathan Vijay; Haffner Steven M; Ramachandran Ambady
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians.
Diabetes care 2003;26(12):3226-9.
2003: Hunt Kelly J; Resendez Roy G; Williams Ken; Haffner Steve M; Stern Michael P; Hazuda Helen P
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".
American journal of epidemiology 2003;158(11):1048-57.
2003: Espeland Mark A; Evans Greg W; Wagenknecht Lynne E; O'Leary Daniel H; Zaccaro Daniel J; Crouse J Robin; Howard George; Haffner Steven M
Site-specific progression of carotid artery intimal-medial thickness.
Atherosclerosis 2003;171(1):137-43.
2003: Haffner S; Cassells H B
Metabolic syndrome - a new risk factor of coronary heart disease?
Diabetes, obesity & metabolism 2003;5(6):359-70.
2003: Williams Ken; Sniderman Allan D; Sattar Naveed; D'Agostino Ralph; Wagenknecht Lynne E; Haffner Steven M
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
Circulation 2003;108(19):2312-6.
2003: Hanley Anthony J G; Wagenknecht Lynne E; D'Agostino Ralph B; Zinman Bernard; Haffner Steven M
Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome.
Diabetes 2003;52(11):2740-7.
2003: Lorenzo Carlos; Okoloise Mayor; Williams Ken; Stern Michael P; Haffner Steven M;
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
Diabetes care 2003;26(11):3153-9.
2003: Festa Andreas; Hanley Anthony J G; Tracy Russell P; D'Agostino Ralph; Haffner Steven M
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
Circulation 2003;108(15):1822-30.
2003: Wagenknecht Lynne E; Langefeld Carl D; Scherzinger Ann L; Norris Jill M; Haffner Steven M; Saad Mohammed F; Bergman Richard N
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
Diabetes 2003;52(10):2490-6.
2003: Haffner Steven M; D'Agostino Ralph; Festa Andreas; Bergman Richard N; Mykkänen Leena; Karter Andrew; Saad Mohammed F; Wagenknecht Lynne E
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
Diabetes care 2003;26(10):2796-803.
2003: Ryan Donna H; Espeland Mark A; Foster Gary D; Haffner Steven M; Hubbard Van S; Johnson Karen C; Kahn Steven E; Knowler William C; Yanovski Susan Z;
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.
Controlled clinical trials 2003;24(5):610-28.
2003: Hunt Kelly J; Williams Ken; Rivera David; O'Leary Daniel H; Haffner Steve M; Stern Michael P; González Villalpando Clicerio
Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(10):1845-50.
2003: Haffner Steven M
Managing dyslipidemia in adults with diabetes.
Managed care (Langhorne, Pa.) 2003;12(9 Suppl):10-5.
2003: Haffner Steven; Taegtmeyer Heinrich
Epidemic obesity and the metabolic syndrome.
Circulation 2003;108(13):1541-5.
2003: Domanski Michael; Krause-Steinrauf Heidi; Deedwania Prakash; Follmann Dean; Ghali Jalal K; Gilbert Edward; Haffner Steven; Katz Richard; Lindenfeld JoAnn; Lowes Brian D; Martin Wade; McGrew Frank; Bristow Michael R;
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
Journal of the American College of Cardiology 2003;42(5):914-22.
2003: Haffner Steven M
Insulin resistance, inflammation, and the prediabetic state.
The American journal of cardiology 2003;92(4A):18J-26J.
2003: Mak Koon-Hou; Haffner Steven M
Diabetes abolishes the gender gap in coronary heart disease.
European heart journal 2003;24(15):1385-6.
2003: Bergman Richard N; Zaccaro Daniel J; Watanabe Richard M; Haffner Steven M; Saad Mohammed F; Norris Jill M; Wagenknecht Lynne E; Hokanson James E; Rotter Jerome I; Rich Steven S
Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin.
Diabetes 2003;52(8):2168-74.
2003: Meigs James B; Wilson Peter W F; Nathan David M; D'Agostino Ralph B; Williams Ken; Haffner Steven M
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
Diabetes 2003;52(8):2160-7.
2003: Pladevall Manel; Williams Keoki; Guyer Heidi; Sadurní Josep; Falces Carles; Ribes Anna; Paré Carles; Brotons Carlos; Gabriel Rafael; Serrano-Ríos Manuel; Haffner Steven
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study.
Journal of hypertension 2003;21(8):1467-73.
2003: González-Villalpando Clicerio; Rivera-Martínez David; Cisneros-Castólo Martín; González-Villalpando Ma Elena; Simón Jesús; Williams Ken; Haffner Steven; Stern Michael
Seven-year incidence and progression of obesity. Characterization of body fat pattern evolution in low-income Mexico City urban population.
Archives of medical research 2003;34(4):348-53.
2003: Haffner Steven M
Pre-diabetes, insulin resistance, inflammation and CVD risk.
Diabetes research and clinical practice 2003;61 Suppl 1():S9-S18.
2003: Haffner Steven M
Statin therapy for the treatment of diabetic dyslipidemia.
Diabetes/metabolism research and reviews 2003;19(4):280-7.
2003: Sattar Naveed; Gaw Allan; Scherbakova Olga; Ford Ian; O'Reilly Denis St J; Haffner Steven M; Isles Chris; Macfarlane Peter W; Packard Chris J; Cobbe Stuart M; Shepherd James
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Circulation 2003;108(4):414-9.
2003: Burke James P; Williams Ken; Narayan K M Venkat; Leibson Cynthia; Haffner Steven M; Stern Michael P
A population perspective on diabetes prevention: whom should we target for preventing weight gain?
Diabetes care 2003;26(7):1999-2004.
2003: Wagenknecht Lynne E; Zaccaro Daniel; Espeland Mark A; Karter Andrew J; O'Leary Daniel H; Haffner Steven M
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(6):1035-41.
2003: Festa Andreas; D'Agostino Ralph; Rich Steven S; Jenny Nancy S; Tracy Russell P; Haffner Steven M
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Circulation 2003;107(19):2422-7.
2003: Alexander Charles M; Landsman Pamela B; Teutsch Steven M; Haffner Steven M;
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
Diabetes 2003;52(5):1210-4.
2003: Henkin Leora; Bergman Richard N; Bowden Donald W; Ellsworth Darrell L; Haffner Steven M; Langefeld Carl D; Mitchell Braxton D; Norris Jill M; Rewers Marian; Saad Mohammed F; Stamm Elizabeth; Wagenknecht Lynne E; Rich Stephen S
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.
Annals of epidemiology 2003;13(4):211-7.
2003: Stern Michael P; Williams Ken; Haffner Steven M
Do we need the oral glucose tolerance test to identify future cases of type 2 diabetes?
Diabetes care 2003;26(3):940-1.
2003: Goff David C; Zaccaro Daniel J; Haffner Steven M; Saad Mohammed F;
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study.
Diabetes care 2003;26(3):805-9.
2003: Hanley Anthony J G; Williams Ken; Gonzalez Clicerio; D'Agostino Ralph B; Wagenknecht Lynne E; Stern Michael P; Haffner Steven M;
Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.
Diabetes 2003;52(2):463-9.
2003: Haffner Steven M;
Management of dyslipidemia in adults with diabetes.
Diabetes care 2003;26 Suppl 1():S83-6.
2003: Hokanson John E; Langefeld Carl D; Mitchell Braxton D; Lange Leslie A; Goff David C; Haffner Steven M; Saad Mohammad F; Rotter Jerome I
Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study.
Human heredity 2003;55(1):46-50.
2002: Sowers James R; Haffner Steven
Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.
Hypertension 2002;40(6):781-8.
2002: Plutzky Jorge; Viberti Giancarlo; Haffner Steven
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
Journal of diabetes and its complications 2002;16(6):401-15.
2002: Festa A; D'Agostino R; Tracy R P; Haffner S M
C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(11):939-43.
2002: Han Thang S; Sattar Naveed; Williams Ken; Gonzalez-Villalpando Clicerio; Lean Michael E J; Haffner Steven M
Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.
Diabetes care 2002;25(11):2016-21.
2002: Haffner Steven M
Metabolic syndrome, diabetes and coronary heart disease.
International journal of clinical practice. Supplement 2002;(132):31-7.
2002: Haffner Steven M
Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
The American journal of cardiology 2002;90(8A):55i-61i.
2002: Abate Nicola; Haffner Steven M; Garg Abhimanyu; Peshock Ronald M; Grundy Scott M
Sex steroid hormones, upper body obesity, and insulin resistance.
The Journal of clinical endocrinology and metabolism 2002;87(10):4522-7.
2002: Stern Michael P; Fatehi Pedram; Williams Ken; Haffner Steven M
Predicting future cardiovascular disease: do we need the oral glucose tolerance test?
Diabetes care 2002;25(10):1851-6.
2002: Viberti Giancarlo; Kahn Steven E; Greene Douglas A; Herman William H; Zinman Bernard; Holman Rury R; Haffner Steven M; Levy Daniel; Lachin John M; Berry Rhona A; Heise Mark A; Jones Nigel P; Freed Martin I
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Diabetes care 2002;25(10):1737-43.
2002: Haustein K O; Haffner S; Woodcock B G
A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients.
International journal of clinical pharmacology and therapeutics 2002;40(9):404-18.
2002: Fischer S; Hanefeld M; Haffner S M; Fusch C; Schwanebeck U; Köhler C; Fücker K; Julius U
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.
Acta diabetologica 2002;39(3):105-10.
2002: Han Thang S; Williams Ken; Sattar Naveed; Hunt Kelly J; Lean Michael E J; Haffner Steven M
Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
Obesity research 2002;10(9):923-31.
2002: Hunt Kelly J; Williams Ken; Resendez Roy G; Hazuda Helen P; Haffner Steve M; Stern Michael P
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox".
Diabetes care 2002;25(9):1557-63.
2002: Haffner Steven M; Greenberg Andrew S; Weston Wayde M; Chen Hongzi; Williams Ken; Freed Martin I
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Circulation 2002;106(6):679-84.
2002: Hanley Anthony J G; Karter Andrew J; Festa Andreas; D'Agostino Ralph; Wagenknecht Lynne E; Savage Peter; Tracy Russell P; Saad Mohammed F; Haffner Steven;
Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study.
Diabetes 2002;51(8):2642-7.
2002: Haffner Steven M
Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials.
International journal of clinical practice. Supplement 2002;(129):33-9.
2002: Haffner Steven M; Goldberg Ronald B
New strategies for the treatment of diabetic dyslipidemia.
Diabetes care 2002;25(7):1237-9.
2002: Hanley Anthony J G; Williams Ken; Stern Michael P; Haffner Steven M
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
Diabetes care 2002;25(7):1177-84.
2002: Hu Frank B; Stampfer Meir J; Haffner Steven M; Solomon Caren G; Willett Walter C; Manson JoAnn E
Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.
Diabetes care 2002;25(7):1129-34.
2002: Haffner Steven M
Glucose-tolerance testing in acute myocardial infarction.
Lancet 2002;359(9324):2127-8.
2002: Haffner Steven M; Hanley Anthony J G
Do increased proinsulin concentrations explain the excess risk of coronary heart disease in diabetic and prediabetic subjects?
Circulation 2002;105(17):2008-9.
2002: Stern Michael P; Williams Ken; Haffner Steven M
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
Annals of internal medicine 2002;136(8):575-81.
2002: Hanley Anthony J G; D'Agostino Ralph; Wagenknecht Lynne E; Saad Mohammed F; Savage Peter J; Bergman Richard; Haffner Steven M;
Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
Diabetes 2002;51(4):1263-70.
2002: Festa Andreas; D'Agostino Ralph; Tracy Russell P; Haffner Steven M;
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
Diabetes 2002;51(4):1131-7.
2002: Hanefeld M; Haffner S M; Menschikowski M; Koehler C; Temelkova-Kurktschiev T; Wildbrett J; Fischer S
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.
Diabetes research and clinical practice 2002;55(3):221-7.
2002: Lorenzo Carlos; Serrano-Rios Manuel; Martinez-Larrad Maria T; Gabriel Rafael; Williams Ken; Gonzalez-Villalpando Clicerio; Stern Michael P; Hazuda Helen P; Haffner Steven
Prevalence of hypertension in Hispanic and non-Hispanic white populations.
Hypertension 2002;39(2):203-8.
2002: Haffner Steven M
Cholesterol goals established for patients with diabetes and metabolic syndrome.
The American journal of managed care 2002;Suppl():6-7.
2001: Lorenzo C; Serrano-Rios M; Martinez-Larrad M T; Gabriel R; Williams K; Gonzalez-Villalpando C; Stern M P; Hazuda H P; Haffner S M
Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study.
Diabetes care 2001;24(12):2059-64.
2001: Festa A; D'Agostino R; Williams K; Karter A J; Mayer-Davis E J; Tracy R P; Haffner S M
The relation of body fat mass and distribution to markers of chronic inflammation.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2001;25(10):1407-15.
2001: Meigs J B; Haffner S M; Nathan D M; D'Agostino R B; Wilson P W
Sample exchange to compare insulin measurements between the San Antonio Heart Study and the Framingham Offspring Study.
Journal of clinical epidemiology 2001;54(10):1031-6.
2001: Haffner S
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point.
International journal of clinical practice. Supplement 2001;(123):24-6.
2001: Burke J P; Williams K; Haffner S M; Villalpando C G; Stern M P
Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico.
Diabetes care 2001;24(9):1573-8.
2001: Haffner S M
Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors.
Circulation 2001;103(3):346-7.
2000: Bell R A; Mayer-Davis E J; Martin M A; D'Agostino R B; Haffner S M
Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
Diabetes care 2000;23(11):1630-6.
2000: Festa A; D'Agostino R; Rautaharju P; Mykkänen L; Haffner S M
Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.
The American journal of cardiology 2000;86(10):1117-22.
2000: Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy R P; Haffner S M
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
Kidney international 2000;58(4):1703-10.
2000: Vauhkonen I K; Niskanen L K; Mykkänen L; Haffner S M; Uusitupa M I; Laakso M
Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(2):251-60.
2000: Goff D C; D'Agostino R B; Haffner S M; Saad M F; Wagenknecht L E
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.
Diabetes care 2000;23(7):1006-11.
2000: Festa A; D'Agostino R; Howard G; Mykkänen L; Tracy R P; Haffner S M
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
Circulation 2000;102(1):42-7.
2000: Haffner S M
Secondary prevention of coronary heart disease: the role of fibric acids.
Circulation 2000;102(1):2-4.
2000: Haffner S M
Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 2():S56-8.
2000: Haffner S M; Agostino R D; Saad M F; O'Leary D H; Savage P J; Rewers M; Selby J; Bergman R N; Mykkänen L
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).
The American journal of cardiology 2000;85(12):1395-400.
2000: Ballantyne C M; Grundy S M; Oberman A; Kreisberg R A; Havel R J; Frost P H; Haffner S M
Hyperlipidemia: diagnostic and therapeutic perspectives.
The Journal of clinical endocrinology and metabolism 2000;85(6):2089-112.
2000: Festa A; D'Agostino R; Hales C N; Mykkänen L; Haffner S M
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Diabetes care 2000;23(5):624-8.
2000: Haffner S M
Coronary heart disease in patients with diabetes.
The New England journal of medicine 2000;342(14):1040-2.
2000: Haffner S M; Ashraf T
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents.
Managed care interface 2000;13(3):52-8.
2000: Haffner S M
Obesity and the metabolic syndrome: the San Antonio Heart Study.
The British journal of nutrition 2000;83 Suppl 1():S67-70.
2000: Haffner S M; Mykkänen L; Festa A; Burke J P; Stern M P
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.
Circulation 2000;101(9):975-80.
2000: Haffner S M
Clinical relevance of the oxidative stress concept.
Metabolism: clinical and experimental 2000;49(2 Suppl 1):30-4.
2000: Haffner S M
Oxidative stress: introduction.
Metabolism: clinical and experimental 2000;49(2 Suppl 1):1-2.
1999: Haffner S M; Alexander C M; Cook T J; Boccuzzi S J; Musliner T A; Pedersen T R; Kjekshus J; Pyörälä K
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1999;159(22):2661-7.
1999: Eriksson J; Valle T; Lindström J; Haffner S; Louheranta A; Uusitupa M; Tuomilehto J
Leptin concentrations and their relation to body fat distribution and weight loss--a prospective study in individuals with impaired glucose tolerance. DPS-study group.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(11):616-9.
1999: Mykkänen L; Kuusisto J; Haffner S M; Laakso M; Austin M A
LDL size and risk of coronary heart disease in elderly men and women.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(11):2742-8.
1999: Festa A; D'Agostino R; Mykkänen L; Tracy R P; Hales C N; Howard B V; Haffner S M
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
Diabetes care 1999;22(10):1688-93.
1999: Haffner S M; D'Agostino R; Goff D; Howard B; Festa A; Saad M F; Mykkänen L
LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(9):2234-40.
1999: Mykkänen L; Zaccaro D J; Hales C N; Festa A; Haffner S M
The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.
Diabetologia 1999;42(9):1060-6.
1999: Haffner S M
Metabolic predictors of hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1999;17(3):S23-8.
1999: Haffner S M
Patients with type 2 diabetes: the case for primary prevention.
The American journal of medicine 1999;107(2A):43S-45S.
1999: Festa A; Shnawa N; Krugluger W; Hopmeier P; Schernthaner G; Haffner S M
Relative hypoleptinaemia in women with mild gestational diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(8):656-62.
1999: Festa A; D'Agostino R; Rautaharju P; O'Leary D H; Rewers M; Mykkänen L; Haffner S M
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1999;30(8):1566-71.
1999: Henkin L; Zaccaro D; Haffner S; Karter A; Rewers M; Sholinsky P; Wagenknecht L
Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
Annals of epidemiology 1999;9(5):290-6.
1999: Haffner S M
Epidemiology of insulin resistance and its relation to coronary artery disease.
The American journal of cardiology 1999;84(1A):11J-14J.
1999: Burke J P; Williams K; Gaskill S P; Hazuda H P; Haffner S M; Stern M P
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study.
Archives of internal medicine 1999;159(13):1450-6.
1999: González-Villalpando C; Stern M P; Haffner S M; González Villapando M E; Gaskill S; Rivera Martínez D
Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure.
Journal of cardiovascular risk 1999;6(3):177-81.
1999: Gonzalez C; Stern M P; Gonzalez E; Rivera D; Simon J; Islas S; Haffner S
The Mexico City Diabetes Study: a population-based approach to the study of genetic and environmental interactions in the pathogenesis of obesity and diabetes.
Nutrition reviews 1999;57(5 Pt 2):S71-6; discussion S76-7.
1999: MacCluer J W; Stern M P; Almasy L; Atwood L A; Blangero J; Comuzzie A G; Dyke B; Haffner S M; Henkel R D; Hixson J E; Kammerer C M; Mahaney M C; Mitchell B D; Rainwater D L; Samollow P B; Sharp R M; VandeBerg J L; Williams J T
Genetics of atherosclerosis risk factors in Mexican Americans.
Nutrition reviews 1999;57(5 Pt 2):S59-65.
1999: Rader D J; Haffner S M
Role of fibrates in the management of hypertriglyceridemia.
The American journal of cardiology 1999;83(9B):30F-35F.
1999: Haffner S M
Diabetes, hyperlipidemia, and coronary artery disease.
The American journal of cardiology 1999;83(9B):17F-21F.
1999: Festa A; Krugluger W; Shnawa N; Hopmeier P; Haffner S M; Schernthaner G
Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1999;84(5):1695-9.
1999: Haffner S M
Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Diabetes care 1999;22 Suppl 3():C54-6.
1999: Haffner S M; D'Agostino R; Mykkänen L; Tracy R; Howard B; Rewers M; Selby J; Savage P J; Saad M F
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
Diabetes care 1999;22(4):562-8.
1999: Haffner S M; Mykkänen L; Rainwater D L; Karhapää P; Laakso M
Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?
Obesity research 1999;7(2):164-9.
1999: Festa A; D'Agostino R; Mykkänen L; Tracy R; Howard B V; Haffner S M
Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):605-10.
1999: Festa A; D'Agostino R; Mykkänen L; Tracy R P; Zaccaro D J; Hales C N; Haffner S M
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):562-8.
1999: Rainwater D L; Mitchell B D; Comuzzie A G; Haffner S M
Relationship of low-density lipoprotein particle size and measures of adiposity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(2):180-9.
1999: Festa A; Shnawa N; Schernthaner G; Haffner S M
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107(7):447-52.
1998: Vauhkonen I; Niskanen L; Haffner S; Kainulainen S; Uusitupa M; Laakso M
Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus.
European journal of endocrinology / European Federation of Endocrine Societies 1998;139(6):598-604.
1998: Haffner S M
Epidemiology of type 2 diabetes: risk factors.
Diabetes care 1998;21 Suppl 3():C3-6.
1998: Wagenknecht L E; D'Agostino R B; Haffner S M; Savage P J; Rewers M
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
Diabetes care 1998;21(11):1812-8.
1998: Dubuisson J T; Wagenknecht L E; D'Agostino R B; Haffner S M; Rewers M; Saad M F; Laws A; Herrington D M
Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
Diabetes care 1998;21(11):1790-6.
1998: Haffner S M
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Endocrine reviews 1998;19(5):583-92.
1998: Howard B V; Mayer-Davis E J; Goff D; Zaccaro D J; Laws A; Robbins D C; Saad M F; Selby J; Hamman R F; Krauss R M; Haffner S M
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
Metabolism: clinical and experimental 1998;47(10):1174-9.
1998: Haffner S M
Issues in management: the role of insulin in cardiovascular outcomes.
Diabetes/metabolism reviews 1998;14 Suppl 1():S51-6.
1998: Haffner S M; Miettinen H; Mykkänen L; Stern M P
Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(9):899-905.
1998: Karhunen L J; Lappalainen R I; Haffner S M; Valve R H; Tuorila H; Miettinen H; Uusitupa M I
Serum leptin, food intake and preferences for sugar and fat in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(8):819-21.
1998: Rainwater D L; Haffner S M
Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(8):1335-41.
1998: Howard G; Bergman R; Wagenknecht L E; Haffner S M; Savage P J; Saad M F; Laws A; D'Agostino R B
Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Annals of epidemiology 1998;8(6):358-69.
1998: Haffner S M; D'Agostino R; Mykkänen L; Hales C N; Savage P J; Bergman R N; O'Leary D; Rewers M; Selby J; Tracy R; Saad M F
Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study.
Stroke; a journal of cerebral circulation 1998;29(8):1498-503.
1998: Burke J P; Haffner S M; Gaskill S P; Williams K L; Stern M P
Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria.
Diabetes care 1998;21(8):1266-70.
1998: Haffner S M; Mykkänen L A; Gonzalez C C; Stern M P
Leptin concentrations do not predict weight gain: the Mexico City Diabetes Study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(7):695-9.
1998: Haffner S M; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
The New England journal of medicine 1998;339(4):229-34.
1998: Wei M; Gaskill S P; Haffner S M; Stern M P
Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
Diabetes care 1998;21(7):1167-72.
1998: Snehalatha C; Ramachandran A; Satyavani K; Vijay V; Haffner S M
Plasma leptin is not associated with insulin resistance and proinsulin in non-diabetic South Asian Indians.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(6):480-4.
1998: Mykkänen L; Zaccaro D J; Wagenknecht L E; Robbins D C; Gabriel M; Haffner S M
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.
Diabetes 1998;47(5):793-800.
1998: Johnston P S; Feig P U; Coniff R F; Krol A; Davidson J A; Haffner S M
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
Diabetes care 1998;21(3):409-15.
1998: Mayer-Davis E J; D'Agostino R; Karter A J; Haffner S M; Rewers M J; Saad M; Bergman R N
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
JAMA : the journal of the American Medical Association 1998;279(9):669-74.
1998: Snehalatha C; Ramachandran A; Satyavani K; Vijay V; Haffner S M
Specific insulin and proinsulin concentrations in nondiabetic South Indians.
Metabolism: clinical and experimental 1998;47(2):230-3.
1998: Anand S S; Enas E A; Pogue J; Haffner S; Pearson T; Yusuf S
Elevated lipoprotein(a) levels in South Asians in North America.
Metabolism: clinical and experimental 1998;47(2):182-4.
1998: Haffner S M
Management of dyslipidemia in adults with diabetes.
Diabetes care 1998;21(1):160-78.
1998: Miettinen H; Lehto S; Salomaa V; Mähönen M; Niemelä M; Haffner S M; Pyörälä K; Tuomilehto J
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.
Diabetes care 1998;21(1):69-75.
1998: Liese A D; Mayer-Davis E J; Haffner S M
Development of the multiple metabolic syndrome: an epidemiologic perspective.
Epidemiologic reviews 1998;20(2):157-72.
1998: Shoff S M; Newcomb P A; Mares-Perlman J A; Klein B E; Haffner S M; Storer B E; Klein R
Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin.
Nutrition and cancer 1998;30(3):207-12.
1997: Rainwater D L; Mitchell B D; Mahaney M C; Haffner S M
Genetic relationship between measures of HDL phenotypes and insulin concentrations.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(12):3414-9.
1997: Mykkänen L; Haffner S M; Hales C N; Rönnemaa T; Laakso M
The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects.
Diabetes 1997;46(12):1990-5.
1997: Ramachandran A; Snehalatha C; Vijay V; Satyavani K; Latha E; Haffner S M
Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(11):937-41.
1997: Sanchez-Lugo L; Mayer-Davis E J; Howard G; Selby J V; Ayad M F; Rewers M; Haffner S
Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS).
The American journal of clinical nutrition 1997;66(5):1224-31.
1997: Haffner S M; Mykkänen L; Stern M P
Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy.
American journal of epidemiology 1997;146(7):581-5.
1997: Haffner S M
Progress in population analyses of the insulin resistance syndrome.
Annals of the New York Academy of Sciences 1997;827():1-12.
1997: Mykkänen L; Zaccaro D J; O'Leary D H; Howard G; Robbins D C; Haffner S M
Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1997;28(9):1710-6.
1997: Haffner S M
Is there a glycemic threshold?
Archives of internal medicine 1997;157(16):1791.
1997: Jaquish C E; Blangero J; Haffner S M; Stern M P; MacCluer J W
Quantitative genetics of serum sex hormone-binding globulin levels in participants in the San Antonio Family Heart Study.
Metabolism: clinical and experimental 1997;46(9):988-91.
1997: Haffner S M; Hanefeld M; Fischer S; Fuçker K; Leonhardt W
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.
Diabetes care 1997;20(9):1430-4.
1997: Töyry J P; Niskanen L K; Mäntysaari M J; Länsimies E A; Haffner S M; Miettinen H J; Uusitupa M I
Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects.
Circulation 1997;96(4):1185-91.
1997: Haffner S M; Miettinen H
Insulin resistance implications for type II diabetes mellitus and coronary heart disease.
The American journal of medicine 1997;103(2):152-62.
1997: Haffner S M
Impaired glucose tolerance, insulin resistance and cardiovascular disease.
Diabetic medicine : a journal of the British Diabetic Association 1997;14 Suppl 3():S12-8.
1997: Mykkänen L; Haffner S M; Rönnemaa T; Bergman R N; Laakso M
Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.
American journal of epidemiology 1997;146(4):315-21.
1997: Lehto S; Rönnemaa T; Haffner S M; Pyörälä K; Kallio V; Laakso M
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.
Diabetes 1997;46(8):1354-9.
1997: Mykkänen L; Haffner S M; Rainwater D L; Karhapää P; Miettinen H; Laakso M
Relationship of LDL size to insulin sensitivity in normoglycemic men.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(7):1447-53.
1997: Haffner S M
Impaired glucose tolerance--is it relevant for cardiovascular disease?
Diabetologia 1997;40 Suppl 2():S138-40.
1997: Haffner S M; Gonzalez C; Mykkänen L; Stern M
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.
Diabetologia 1997;40(7):830-7.
1997: Niskanen L K; Haffner S; Karhunen L J; Turpeinen A K; Miettinen H; Uusitupa M I
Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(1):61-7.
1997: Haffner S M; Miettinen H; Stern M P
The homeostasis model in the San Antonio Heart Study.
Diabetes care 1997;20(7):1087-92.
1997: Haffner S M; Miettinen H; Stern M P
Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men.
Diabetologia 1997;40(6):711-7.
1997: Karhunen L; Haffner S; Lappalainen R; Turpeinen A; Miettinen H; Uusitupa M
Serum leptin and short-term regulation of eating in obese women.
Clinical science (London, England : 1979) 1997;92(6):573-8.
1997: Haffner S M; Miettinen H; Karhapää P; Mykkänen L; Laakso M
Leptin concentrations, sex hormones, and cortisol in nondiabetic men.
The Journal of clinical endocrinology and metabolism 1997;82(6):1807-9.
1997: Ramachandran A; Snehalatha C; Viswanathan V; Viswanathan M; Haffner S M
Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites.
Diabetes research and clinical practice 1997;36(2):121-5.
1997: Wagenknecht L E; D'Agostino R; Savage P J; O'Leary D H; Saad M F; Haffner S M
Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS).
Stroke; a journal of cerebral circulation 1997;28(5):999-1005.
1997: Haffner S M; Miettinen H; Mykkänen L; Karhapää P; Rainwater D L; Laakso M
Leptin concentrations and insulin sensitivity in normoglycemic men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(5):393-9.
1997: González Villalpando M E; González Villalpando C; Arredondo Pérez B; Martínez Díaz S V; Mitchell B; Rivera Martínez D; Klein R; Haffner S M; Stern M P
Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas.
Diabetes care 1997;20(5):773-7.
1997: Niskanen L; Haffner S; Karhunen L J; Turpeinen A K; Miettinen H; Uusitupa M I
Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(4):309-13.
1997: Turpeinen A K; Haffner S M; Louheranta A M; Niskanen L K; Miettinen H; Uusitupa M I
Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(4):284-7.
1997: Haffner S M
The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease.
Diabetes care 1997;20(4):469-71.
1997: Edelstein S L; Knowler W C; Bain R P; Andres R; Barrett-Connor E L; Dowse G K; Haffner S M; Pettitt D J; Sorkin J D; Muller D C; Collins V R; Hamman R F
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.
Diabetes 1997;46(4):701-10.
1997: Haffner S M
The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities.
Journal of diabetes and its complications 1997;11(2):69-76.
1997: Wei M; Stern M P; Haffner S M
Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking.
Annals of epidemiology 1997;7(2):81-6.
1997: Wei M; Gaskill S P; Haffner S M; Stern M P
Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.
Obesity research 1997;5(1):16-23.
1997: Haffner S M
Epidemiology of hypertension and insulin resistance syndrome.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1997;15(1):S25-30.
1997: Haffner S M; Miettinen H; Stern M P
Are risk factors for conversion to NIDDM similar in high and low risk populations?
Diabetologia 1997;40(1):62-6.
1997: Laws A; Hoen H M; Selby J V; Saad M F; Haffner S M; Howard B V
Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):64-71.
1997: Mayer-Davis E J; Monaco J H; Hoen H M; Carmichael S; Vitolins M Z; Rewers M J; Haffner S M; Ayad M F; Bergman R N; Karter A J
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)
The American journal of clinical nutrition 1997;65(1):79-87.
1997: Haffner S M; Howard G; Mayer E; Bergman R N; Savage P J; Rewers M; Mykkänen L; Karter A J; Hamman R; Saad M F
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
Diabetes 1997;46(1):63-9.
1997: Gonzalez Villalpando C; Rivera Martinez D; Arredondo Perez B; Martinez Diaz S; Gonzalez Villalpando M E; Haffner S M; Stern M P
High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey.
Archives of medical research 1997;28(4):543-7.
1996: Wei M; Mitchell B D; Haffner S M; Stern M P
Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1996;144(11):1058-65.
1996: Miettinen H; Haffner S M; Lehto S; Rönnemaa T; Pyörälà K; Laakso M
Retinopathy predicts coronary heart disease events in NIDDM patients.
Diabetes care 1996;19(12):1445-8.
1996: Jaquish C E; Blangero J; Haffner S M; Stern M P; Maccluer J W
Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans.
Human heredity 1996;46(6):301-9.
1996: Wei M; Gonzalez C; Haffner S M; O'Leary D H; Stern M P
Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(11):1388-92.
1996: Miettinen H; Haffner S M; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.
Stroke; a journal of cerebral circulation 1996;27(11):2033-9.
1996: Niskanen L; Rauramaa R; Miettinen H; Haffner S M; Mercuri M; Uusitupa M
Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects.
Stroke; a journal of cerebral circulation 1996;27(11):1986-92.
1996: Karter A J; Mayer-Davis E J; Selby J V; D'Agostino R B; Haffner S M; Sholinsky P; Bergman R; Saad M F; Hamman R F
Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
Diabetes 1996;45(11):1547-55.
1996: Haffner S M; Gingerich R L; Miettinen H; Stern M P
Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(10):904-8.
1996: Haffner S M; Miettinen H; Gaskill S P; Stern M P
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance.
Diabetologia 1996;39(10):1201-7.
1996: Haffner S M; Kennedy E; Gonzalez C; Stern M P; Miettinen H
A prospective analysis of the HOMA model. The Mexico City Diabetes Study.
Diabetes care 1996;19(10):1138-41.
1996: Haffner S M; Moss S E; Klein B E; Klein R
Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Diabetes care 1996;19(10):1045-50.
1996: Haffner S M; Laakso M; Miettinen H; Mykkänen L; Karhapää P; Rainwater D L
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men.
The Journal of clinical endocrinology and metabolism 1996;81(10):3697-701.
1996: D'Agostino R B; Burke G; O'Leary D; Rewers M; Selby J; Savage P J; Saad M F; Bergman R N; Howard G; Wagenknecht L; Haffner S M
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study.
Stroke; a journal of cerebral circulation 1996;27(10):1744-9.
1996: Haffner S M; Miettinen H; Gaskill S P; Stern M P
Metabolic precursors of hypertension. The San Antonio Heart Study.
Archives of internal medicine 1996;156(17):1994-2001.
1996: Haffner S M; Stern M P; Miettinen H; Robbins D; Howard B V
Apolipoprotein E polymorphism and LDL size in a biethnic population.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(9):1184-8.
1996: Haffner S M
Cardiovascular risk factors and the prediabetic syndrome.
Annals of medicine 1996;28(4):363-70.
1996: Wei M; Valdez R A; Mitchell B D; Haffner S M; Stern M P; Hazuda H P
Migration status, socioeconomic status, and mortality rates in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.
Annals of epidemiology 1996;6(4):307-13.
1996: Haffner S M; Miettinen H; Stern M P; Agil A; Jialal I
Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
Metabolism: clinical and experimental 1996;45(7):876-81.
1996: Haffner S M; Stern M P; Miettinen H; Wei M; Gingerich R L
Leptin concentrations in diabetic and nondiabetic Mexican-Americans.
Diabetes 1996;45(6):822-4.
1996: Haffner S M; D'Agostino R; Saad M F; Rewers M; Mykkänen L; Selby J; Howard G; Savage P J; Hamman R F; Wagenknecht L E
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
Diabetes 1996;45(6):742-8.
1996: Miettinen H; Lehto S; Saikku P; Haffner S M; Rönnemaa T; Pyörälä K; Laakso M
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.
European heart journal 1996;17(5):682-8.
1996: Howard G; O'Leary D H; Zaccaro D; Haffner S; Rewers M; Hamman R; Selby J V; Saad M F; Savage P; Bergman R
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
Circulation 1996;93(10):1809-17.
1996: Haffner S M; Miettinen H; Stern M P
Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes.
The Journal of clinical endocrinology and metabolism 1996;81(5):1846-51.
1996: Haffner S M; Shaten J; Stern M P; Smith G D; Kuller L
Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial.
American journal of epidemiology 1996;143(9):889-97.
1996: Jaquish C E; Mahaney M C; Blangero J; Haffner S M; Stern M P; MacCluer J W
Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans.
Atherosclerosis 1996;122(1):117-25.
1996: Haffner S M
The insulin resistance syndrome revisited.
Diabetes care 1996;19(3):275-7.
1996: Garg A; Haffner S M
Insulin resistance and atherosclerosis.
Diabetes care 1996;19(3):274.
1996: Mykkanen L; Haffner S M; Ronnemaa T; Watanabe R M; Laakso M
Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?
Journal of hypertension 1996;14(3):399-405.
1996: Kammerer C M; VandeBerg J L; Haffner S M; Hixson J E
Apolipoprotein B (apo B) signal peptide length polymorphisms are associated with apo B, low density lipoprotein cholesterol, and glucose levels in Mexican Americans.
Atherosclerosis 1996;120(1-2):37-45.
1996: Comuzzie A G; Blangero J; Mahaney M C; Haffner S M; Mitchell B D; Stern M P; MacCluer J W
Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography.
The Journal of clinical endocrinology and metabolism 1996;81(2):597-600.
1996: Mitchell B D; Kammerer C M; Mahaney M C; Blangero J; Comuzzie A G; Atwood L D; Haffner S M; Stern M P; MacCluer J W
Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):281-8.
1996: Robbins D C; Andersen L; Bowsher R; Chance R; Dinesen B; Frank B; Gingerich R; Goldstein D; Widemeyer H M; Haffner S; Hales C N; Jarett L; Polonsky K; Porte D; Skyler J; Webb G; Gallagher K
Report of the American Diabetes Association's Task Force on standardization of the insulin assay.
Diabetes 1996;45(2):242-56.
1996: Ferrannini E; Muscelli E; Stern M P; Haffner S M
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(1):7-14.
1996: Haffner S M; Miettinen H; Stern M P
Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
Diabetes care 1996;19(1):67-9.
1996: Galvan A Q; Haffner S M; Ferrannini E
Diabetes and hypertension: the scope of the problem.
Blood pressure. Supplement 1996;1():7-9.
1996: Haffner S M
Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes.
Hormone research 1996;45(3-5):233-7.
1996: Haffner S M
Hypertension in the San Antonio Heart Study and the Mexico City Diabetes Study: clinical and metabolic correlates.
Public health reports (Washington, D.C. : 1974) 1996;111 Suppl 2():11-4.
1996: Gonzalez Villalpando C; Stern M P; Arredondo Perez B; Martinez Diaz S; Haffner S
Undiagnosed hypercholesterolemia: a serious health challenge. The Mexico City Diabetes Study.
Archives of medical research 1996;27(1):19-23.
1996: González Villalpando C; Stern M P; Arredondo Pérez B; Martinez Díaz S; González Villalpando M E; Haffner S; Rivera D; Diehl A K
Prevalence of gallbladder disease and associated clinical variables in a low income population of Mexico City.
Archives of medical research 1996;27(2):237-41.
1995: Haffner S M; Miettinen H; Gaskill S P; Stern M P
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
Diabetes 1995;44(12):1386-91.
1995: Haffner S M; González C; Miettinen H; Howard B V; Stern M P
LDL size and subclass pattern in Mexico City residents and San Antonio Mexican Americans.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(12):2136-41.
1995: Wagenknecht L E; Mayer E J; Rewers M; Haffner S; Selby J; Borok G M; Henkin L; Howard G; Savage P J; Saad M F
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.
Annals of epidemiology 1995;5(6):464-72.
1995: Haffner S M; Mykkänen L; Robbins D; Valdez R; Miettinen H; Howard B V; Stern M P; Bowsher R
A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.
Diabetologia 1995;38(11):1328-36.
1995: Singh A T; Rainwater D L; Haffner S M; VandeBerg J L; Shelledy W R; Moore P H; Dyer T D
Effect of diabetes on lipoprotein size.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):1805-11.
1995: Haffner S M; Newcomb P A; Marcus P M; Klein B E; Klein R
Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women.
American journal of epidemiology 1995;142(9):925-34.
1995: Mykkänen L; Haffner S M; Kuusisto J; Pyörälä K; Hales C N; Laakso M
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.
Diabetologia 1995;38(10):1176-82.
1995: Austin M A; Mykkänen L; Kuusisto J; Edwards K L; Nelson C; Haffner S M; Pyörälä K; Laakso M
Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women.
Circulation 1995;92(7):1770-8.
1995: Haffner S M; Stern M P; Miettinen H; Gingerich R; Bowsher R R
Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects.
Diabetes 1995;44(10):1156-60.
1995: Valdez R; González-Villalpando C; Mitchell B D; Haffner S M; Stern M P
Differential impact of obesity in related populations.
Obesity research 1995;3 Suppl 2():223s-232s.
1995: Haffner S M
Risk factors for non-insulin-dependent diabetes mellitus.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(2):S73-6.
1995: Valdez R; Howard B V; Stern M P; Haffner S M
Apolipoprotein E polymorphism and insulin levels in a biethnic population.
Diabetes care 1995;18(7):992-1000.
1995: Haffner S M; Agil A; Mykkanen L; Stern M P; Jialal I
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Diabetes care 1995;18(5):646-53.
1995: Haffner S; Orchard T; Stein E; Schmidt D; LaBelle P
Effect of simvastatin on Lp(a) concentrations.
Clinical cardiology 1995;18(5):261-7.
1995: Newcomb P A; Klein R; Klein B E; Haffner S; Mares-Perlman J; Cruickshanks K J; Marcus P M
Association of dietary and life-style factors with sex hormones in postmenopausal women.
Epidemiology (Cambridge, Mass.) 1995;6(3):318-21.
1995: Haffner S M; Klein B E; Moss S E; Klein R
Lp(a) is not related to retinopathy in diabetic subjects.
European journal of ophthalmology 1995;5(2):119-23.
1995: Monterrosa A E; Haffner S M; Stern M P; Hazuda H P
Sex difference in lifestyle factors predictive of diabetes in Mexican-Americans.
Diabetes care 1995;18(4):448-56.
1995: Mitchell B D; Kammerer C M; Hixson J E; Atwood L D; Hackleman S; Blangero J; Haffner S M; Stern M P; MacCluer J W
Evidence for a major gene affecting postchallenge insulin levels in Mexican-Americans.
Diabetes 1995;44(3):284-9.
1995: Rainwater D L; Ludwig M J; Haffner S M; VandeBerg J L
Lipid and lipoprotein factors associated with variation in Lp(a) density.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(3):313-9.
1995: Haffner S M; Karhapaa P; Rainwater D L; Mykkanen L; Aldrete G; Laakso M
Insulin sensitivity and Lp(a) concentrations in normoglycemic men.
Diabetes care 1995;18(2):193-9.
1995: Haffner S M; Valdez R A
Endogenous sex hormones: impact on lipids, lipoproteins, and insulin.
The American journal of medicine 1995;98(1A):40S-47S.
1995: Bennett P H; Haffner S; Kasiske B L; Keane W F; Mogensen C E; Parving H H; Steffes M W; Striker G E
Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(1):107-12.
1995: González Villalpando C; Stern M P; Haffner S; Arredondo Pérez B; Martínez Diaz S; Islas Andrade S
The insulin resistance syndrome in Mexico. Prevalence and clinical characteristics: a population based study.
Archives of medical research 1995;26 Spec No():S9-15.
1995: González-Villalpando C; Stern M P; Rivera Martínez D; Arredondo Pérez B; Martínez Diaz S; Haffner S
Carotid artery atherosclerosis in a Mexico City population with high carbohydrate intake.
Archives of medical research 1995;26(4):409-13.
1994: Haffner S M; Mykkänen L; Valdez R A; Stern M P; Holloway D L; Monterrosa A; Bowsher R R
Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome.
The Journal of clinical endocrinology and metabolism 1994;79(6):1806-10.
1994: Haffner S M; Bowsher R R; Mykkänen L; Hazuda H P; Mitchell B D; Valdez R A; Gingerich R; Monterossa A; Stern M P
Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
Diabetes 1994;43(12):1490-3.
1994: Mykkänen L; Kuusisto J; Pyörälä K; Laakso M; Haffner S M
Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects.
Journal of hypertension 1994;12(12):1425-32.
1994: Haffner S M; Mykkänen L; Stern M P; Paidi M; Howard B V
Greater effect of diabetes on LDL size in women than in men.
Diabetes care 1994;17(10):1164-71.
1994: Haffner S; González Villalpando C; Hazuda H P; Valdez R; Mykkänen L; Stern M
Prevalence of hypertension in Mexico City and San Antonio, Texas.
Circulation 1994;90(3):1542-9.
1994: Haffner S M; Mykkänen L; Valdez R A; Stern M P
Evaluation of two insulin assays in insulin resistance syndrome (syndrome X).
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(9):1430-7.
1994: Mykkänen L; Rönnemaa T; Marniemi J; Haffner S M; Bergman R; Laakso M
Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(8):1264-71.
1994: Rainwater D L; MacCluer J W; Stern M P; VandeBerg J L; Haffner S M
Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
Diabetes 1994;43(7):942-6.
1994: Siegel D; Saliba P; Haffner S
Glucose and insulin levels during diuretic therapy in hypertensive men.
Hypertension 1994;23(6 Pt 1):688-94.
1994: Haffner S M; Valdez R A; Mykkänen L; Stern M P; Katz M S
Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.
Metabolism: clinical and experimental 1994;43(5):599-603.
1994: Gonzélez C; Stern M P; Mitchell B D; Valdez R A; Haffner S M; Pérez B A
Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Diabetes care 1994;17(5):397-404.
1994: Mykkänen L; Haffner S M; Rönnemaa T; Bergman R; Leino A; Laakso M
Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins?
Metabolism: clinical and experimental 1994;43(4):523-8.
1994: Mykkänen L; Kuusisto J; Haffner S M; Pyörälä K; Laakso M
Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):518-26.
1994: Mykkänen L; Haffner S M; Kuusisto J; Pyorälä K; Laakso M
Microalbuminuria precedes the development of NIDDM.
Diabetes 1994;43(4):552-7.
1994: Haffner S M; Karhapää P; Mykkänen L; Laakso M
Insulin resistance, body fat distribution, and sex hormones in men.
Diabetes 1994;43(2):212-9.
1994: Valdez R; Mitchell B D; Haffner S M; Hazuda H P; Morales P A; Monterrosa A; Stern M P
Predictors of weight change in a bi-ethnic population. The San Antonio Heart Study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1994;18(2):85-91.
1994: Haffner S M; Mykkanen L; Gruber K K; Rainwater D L; Laakso M
Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(1):19-24.
1994: Haffner S M; Frangos M; Williamson J; Santiago J; Valdez R; Aldrete G; Mykkänen L; Gruber K K; Rainwater D L
Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus.
Chemistry and physics of lipids 1994;67-68():223-31.
1994: González-Villalpando C; Stern M P; Arredondo-Pérez B; Mitchell B; Valdéz R; Haffner S
[Tobacco use in Mexico City]
Salud pública de México 1994;36(1):46-50.
1994: González Villalpando C; Stern M P; Arredondo Pérez B; Valdéz R; Mitchell B; Haffner S
Prevalence and detection of hypertension in Mexico.
Archives of medical research 1994;25(3):347-53.
1993: Haffner S M; Mykkänen L; Valdez R A; Katz M S
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.
The Journal of clinical endocrinology and metabolism 1993;77(6):1610-5.
1993: Haffner S M; Klein R; Moss S E; Klein B E
Sex hormones and the incidence of severe retinopathy in male subjects with type I diabetes.
Ophthalmology 1993;100(12):1782-6.
1993: Haffner S M; Valdez R A; Stern M P; Katz M S
Obesity, body fat distribution and sex hormones in men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(11):643-9.
1993: Haffner S M; Mykkänen L; Valdez R A; Paidi M; Stern M P; Howard B V
LDL size and subclass pattern in a biethnic population.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(11):1623-30.
1993: Haffner S M; Gonzales C; Valdez R A; Mykkänen L; Hazuda H P; Mitchell B D; Monterrosa A; Stern M P
Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study.
Diabetologia 1993;36(10):1002-6.
1993: Howard B V; Schneiderman N; Falkner B; Haffner S M; Laws A
Insulin, health behaviors, and lipid metabolism.
Metabolism: clinical and experimental 1993;42(9 Suppl 1):25-35.
1993: Haffner S M; Diehl A K; Valdez R; Mitchell B D; Hazuda H P; Morales P; Stern M P
Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia.
Diabetes care 1993;16(9):1276-84.
1993: Mitchell B D; Valdez R; Hazuda H P; Haffner S M; Monterrosa A; Stern M P
Differences in the prevalence of diabetes and impaired glucose tolerance according to maternal or paternal history of diabetes.
Diabetes care 1993;16(9):1262-7.
1993: Haffner S M; Mykkänen L; Stern M P; Valdez R A; Heisserman J A; Bowsher R R
Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects.
Diabetes 1993;42(9):1297-302.
1993: Stern M P; Valdez R A; Haffner S M; Mitchell B D; Hazuda H P
Stability over time of modern diagnostic criteria for type II diabetes.
Diabetes care 1993;16(7):978-83.
1993: Haffner S M; Valdez R A; Morales P A; Hazuda H P; Stern M P
Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men.
The Journal of clinical endocrinology and metabolism 1993;77(1):56-60.
1993: Haffner S M; Bauer R L
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women.
Metabolism: clinical and experimental 1993;42(6):735-8.
1993: Haffner S M
Lipoprotein(a) and diabetes. An update.
Diabetes care 1993;16(5):835-40.
1993: Stern M P; Morales P A; Valdez R A; Monterrosa A; Haffner S M; Mitchell B D; Hazuda H P
Predicting diabetes. Moving beyond impaired glucose tolerance.
Diabetes 1993;42(5):706-14.
1993: Stern M P; Gonzalez C; Hernandex M; Knapp J A; Hazuda H P; Villapando E; Valdez R A; Haffner S M; Mitchell B D
Performance of semiquantitative food frequency questionnaires in international comparisons. Mexico City versus San Antonio, Texas.
Annals of epidemiology 1993;3(3):300-7.
1993: Haffner S M
Insulin and blood pressure: fact or fantasy?
The Journal of clinical endocrinology and metabolism 1993;76(3):541-3.
1993: González Villalpando C; Stern M P; Valdez R; Mitchell B; Haffner S
[Blood lipid levels and atherogenic risk in an open urban population]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1993;45(2):127-32.
1993: Haffner S M; Morales P A; Gruber M K; Hazuda H P; Stern M P
Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(2):205-10.
1993: Morales P A; Mitchell B D; Valdez R A; Hazuda H P; Stern M P; Haffner S M
Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study.
Diabetes 1993;42(1):154-61.
1993: Haffner S M; Morales P A; Hazuda H P; Stern M P
Level of control of hypertension in Mexican Americans and non-Hispanic whites.
Hypertension 1993;21(1):83-8.
1993: Haffner S M; Mitchell B D; Moss S E; Stern M P; Hazuda H P; Patterson J; Van Heuven W A; Klein R
Is there an ethnic difference in the effect of risk factors for diabetic retinopathy?
Annals of epidemiology 1993;3(1):2-8.
1993: Mitchell B D; Williams-Blangero S; Chakraborty R; Valdez R; Hazuda H P; Haffner S M; Stern M P
A comparison of three methods for assessing Amerindian admixture in Mexican Americans.
Ethnicity & disease 1993;3(1):22-31.
1992: Stern M P; Morales P A; Haffner S M; Valdez R A
Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X").
Hypertension 1992;20(6):802-8.
1992: Gulli G; Ferrannini E; Stern M; Haffner S; DeFronzo R A
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
Diabetes 1992;41(12):1575-86.
1992: Haffner S M; Gruber K K; Aldrete G; Morales P A; Stern M P; Tuttle K R
Increased lipoprotein(a) concentrations in chronic renal failure.
Journal of the American Society of Nephrology : JASN 1992;3(5):1156-62.
1992: Haffner S M; Gruber K K; Morales P A; Hazuda H P; Valdez R A; Mitchell B D; Stern M P
Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study.
American journal of epidemiology 1992;136(9):1060-8.
1992: Haffner S M; Bauer R L
Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(11):869-74.
1992: Haffner S M; Valdez R; Morales P A; Mitchell B D; Hazuda H P; Stern M P
Greater effect of glycemia on incidence of hypertension in women than in men.
Diabetes care 1992;15(10):1277-84.
1992: Haffner S M; Morales P A; Stern M P; Gruber M K
Lp(a) concentrations in NIDDM.
Diabetes 1992;41(10):1267-72.
1992: Haffner S M; Ferrannini E; Hazuda H P; Stern M P
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.
Hypertension 1992;20(1):38-45.
1992: González-Villalpando C; Stern M P; Villalpando E; Hazuda H; Haffner S M; Lisci E
[Prevalence of diabetes and glucose intolerance in a urban population at a low economic level]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1992;44(3):321-8.
1992: Mitchell B D; Haffner S M; Hazuda H P; Valdez R; Stern M P
The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels.
American journal of epidemiology 1992;136(1):12-22.
1992: Haffner S M; Valdez R A; Hazuda H P; Mitchell B D; Morales P A; Stern M P
Prospective analysis of the insulin-resistance syndrome (syndrome X).
Diabetes 1992;41(6):715-22.
1992: Stern M P; Mitchell B D; Haffner S M; Hazuda H P
Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective.
Diabetes care 1992;15(5):638-44.
1992: Stern M P; Gonzalez C; Mitchell B D; Villalpando E; Haffner S M; Hazuda H P
Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio.
Diabetes 1992;41(4):484-92.
1992: Ferrannini E; Stern M P; Galvan A Q; Mitchell B D; Haffner S M
Impact of associated conditions on glycemic control of NIDDM patients.
Diabetes care 1992;15(4):508-14.
1992: Haffner S M; Stern M P; Watanabe R M; Bergman R N
Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans.
European journal of clinical investigation 1992;22(3):147-53.
1992: Haffner S M; Mitchell B D; Valdez R A; Hazuda H P; Morales P A; Stern M P
Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.
American journal of hypertension 1992;5(3):147-53.
1992: Haffner S M; Dunn J F; Katz M S
Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women.
Metabolism: clinical and experimental 1992;41(3):278-84.
1992: Haffner S M; Kushwaha R S; Hazzard W R
Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern.
Metabolism: clinical and experimental 1992;41(3):241-5.
1992: Haffner S M; Mitchell B D; Stern M P; Hazuda H P; Patterson J K
Public health significance of upper body adiposity for non-insulin dependent diabetes mellitus in Mexican Americans.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(3):177-84.
1992: Haffner S M; Moss S E; Klein B E; Klein R
Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Metabolism: clinical and experimental 1992;41(2):194-7.
1992: Haffner S M; Tuttle K R; Rainwater D L
Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.
Metabolism: clinical and experimental 1992;41(2):116-20.
1992: Mitchell B D; Haffner S M; Hazuda H P; Patterson J K; Stern M P
Diabetes and coronary heart disease risk in Mexican Americans.
Annals of epidemiology 1992;2(1-2):101-6.
1991: Stern M P; Haffner S M
Dyslipidemia in type II diabetes. Implications for therapeutic intervention.
Diabetes care 1991;14(12):1144-59.
1991: Haffner S M
Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus.
The Journal of laboratory and clinical medicine 1991;118(2):109-10.
1991: Mitchell B D; Hazuda H P; Haffner S M; Patterson J K; Stern M P
High prevalence of angina pectoris in Mexican-American men. A population with reduced risk of myocardial infarction.
Annals of epidemiology 1991;1(5):415-26.
1991: Haffner S M; Mitchell B D; Stern M P; Hazuda H P
Macrovascular complications in Mexican Americans with type II diabetes.
Diabetes care 1991;14(7):665-71.
1991: Stern M P; Knapp J A; Hazuda H P; Haffner S M; Patterson J K; Mitchell B D
Genetic and environmental determinants of type II diabetes in Mexican Americans. Is there a "descending limb" to the modernization/diabetes relationship?
Diabetes care 1991;14(7):649-54.
1991: Haffner S M; Katz M S; Dunn J F
Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women.
International journal of obesity 1991;15(7):471-8.
1991: Haffner S M; Stern M P; Mitchell B D; Hazuda H P
Predictors of obesity in Mexican Americans.
The American journal of clinical nutrition 1991;53(6 Suppl):1571S-1576S.
1991: Hazuda H P; Mitchell B D; Haffner S M; Stern M P
Obesity in Mexican American subgroups: findings from the San Antonio Heart Study.
The American journal of clinical nutrition 1991;53(6 Suppl):1529S-1534S.
1991: Ferrannini E; Haffner S M; Stern M P; Mitchell B D; Natali A; Hazuda H P; Patterson J K
High blood pressure and insulin resistance: influence of ethnic background.
European journal of clinical investigation 1991;21(3):280-7.
1991: Ferrannini E; Haffner S M; Mitchell B D; Stern M P
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.
Diabetologia 1991;34(6):416-22.
1991: Haffner S M; Mitchell B D; Hazuda H P; Stern M P
Greater influence of central distribution of adipose tissue on incidence of non-insulin-dependent diabetes in women than men.
The American journal of clinical nutrition 1991;53(5):1312-7.
1991: Haffner S M; Tuttle K R; Rainwater D L
Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects.
Diabetes care 1991;14(4):302-7.
1991: Haffner S M; Hazuda H P; Mitchell B D; Patterson J K; Stern M P
Increased incidence of type II diabetes mellitus in Mexican Americans.
Diabetes care 1991;14(2):102-8.
1991: Mitchell B D; Hazuda H P; Haffner S M; Patterson J K; Stern M P
Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study.
Circulation 1991;83(1):45-51.
1990: Ferrannini E; Haffner S M; Stern M P
Insulin sensitivity and hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S169-74.
1990: Haffner S M; Klein R; Dunn J F; Moss S E; Klein B E
Increased testosterone in type I diabetic subjects with severe retinopathy.
Ophthalmology 1990;97(10):1270-4.
1990: Haffner S M; Stern M P; Gruber M K; Hazuda H P; Mitchell B D; Patterson J K
Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?
Arteriosclerosis (Dallas, Tex.) 1990;10(5):727-31.
1990: Haffner S M; Mitchell B D; Stern M P; Hazuda H P; Patterson J K
Decreased prevalence of hypertension in Mexican-Americans.
Hypertension 1990;16(3):225-32; discussion 233-4.
1990: Haffner S M; Stern M P; Dunn J; Mobley M; Blackwell J; Bergman R N
Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.
Metabolism: clinical and experimental 1990;39(8):842-7.
1990: Haffner S M; Diehl A K; Mitchell B D; Stern M P; Hazuda H P
Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus.
American journal of epidemiology 1990;132(2):327-35.
1990: Stern M P; Patterson J K; Mitchell B D; Haffner S M; Hazuda H P
Overweight and mortality in Mexican Americans.
International journal of obesity 1990;14(7):623-9.
1990: Haffner S M; Stern M P; Hazuda H P; Mitchell B D; Patterson J K
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
JAMA : the journal of the American Medical Association 1990;263(21):2893-8.
1990: Haffner S M; Stern M P; Mitchell B D; Hazuda H P; Patterson J K
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
Diabetes 1990;39(3):283-8.
1990: Mitchell B D; Stern M P; Haffner S M; Hazuda H P; Patterson J K
Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study.
American journal of epidemiology 1990;131(3):423-33.
1990: Stern M P; Haffner S M
Type II diabetes and its complications in Mexican Americans.
Diabetes/metabolism reviews 1990;6(1):29-45.
1990: Mitchell B D; Stern M P; Haffner S M; Hazuda H P; Patterson J K
Functional impairment in Mexican Americans and non-Hispanic whites with diabetes.
Journal of clinical epidemiology 1990;43(4):319-27.
1990: Haffner S M; Katz M S; Dunn J F
The relationship of insulin sensitivity and metabolic clearance of insulin to adiposity and sex hormone binding globulin.
Endocrine research 1990;16(3):361-76.
1990: Ferrannini E; Haffner S M; Stern M P
Essential hypertension: an insulin-resistant state.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S18-25.
1989: Diehl A K; Haffner S M; Knapp J A; Hazuda H P; Stern M P
Dietary intake and the prevalence of gallbladder disease in Mexican Americans.
Gastroenterology 1989;97(6):1527-33.
1989: Haffner S M; Stern M P; Hazuda H P; Mitchell B D; Patterson J K; Ferrannini E
Parental history of diabetes is associated with increased cardiovascular risk factors.
Arteriosclerosis (Dallas, Tex.) 1989;9(6):928-33.
1989: Haffner S M; Kushwaha R S; Hazzard W R
Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
European journal of clinical investigation 1989;19(5):486-90.
1989: Haffner S M; Mitchell B D; Pugh J A; Stern M P; Kozlowski M K; Hazuda H P; Patterson J K; Klein R
Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.
Diabetes care 1989;12(8):530-6.
1989: Raboudi S H; Mitchell B D; Stern M P; Eifler C W; Haffner S M; Hazuda H P; Frazier M L
Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans.
Diabetes 1989;38(8):975-80.
1989: Stern M P; Patterson J K; Haffner S M; Hazuda H P; Mitchell B D
Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey.
JAMA : the journal of the American Medical Association 1989;262(3):360-4.
1989: Haffner S M; Diehl A K; Stern M P; Hazuda H P
Central adiposity and gallbladder disease in Mexican Americans.
American journal of epidemiology 1989;129(3):587-95.
1989: Haffner S M; Hazuda H P; Stern M P; Patterson J K; Van Heuven W A; Fong D
Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM.
Diabetes care 1989;12(2):128-34.
1989: Haffner S M; Katz M S; Stern M P; Dunn J F
Association of decreased sex hormone binding globulin and cardiovascular risk factors.
Arteriosclerosis (Dallas, Tex.) 1989;9(1):136-43.
1989: Haffner S M; Katz M S; Stern M P; Dunn J F
Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population.
International journal of obesity 1989;13(1):1-9.
1988: Hazuda H P; Haffner S M; Stern M P; Eifler C W
Effects of acculturation and socioeconomic status on obesity and diabetes in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1988;128(6):1289-301.
1988: Stern M P; Haffner S M
Prospective assessment of metabolic control in diabetes mellitus: the complications question.
JAMA : the journal of the American Medical Association 1988;260(19):2896-7.
1988: Haffner S M; Stern M P; Hazuda H P; Mitchell B D; Patterson J K
Increased insulin concentrations in nondiabetic offspring of diabetic parents.
The New England journal of medicine 1988;319(20):1297-301.
1988: Pugh J A; Stern M P; Haffner S M; Hazuda H P; Patterson J
Detection and treatment of hypercholesterolemia in a biethnic community, 1979-1985.
Journal of general internal medicine 1988;3(4):331-6.
1988: Haffner S M; Fong D; Stern M P; Pugh J A; Hazuda H P; Patterson J K; van Heuven W A; Klein R
Diabetic retinopathy in Mexican Americans and non-Hispanic whites.
Diabetes 1988;37(7):878-84.
1988: Haffner S M; Katz M S; Stern M P; Dunn J F
The relationship of sex hormones to hyperinsulinemia and hyperglycemia.
Metabolism: clinical and experimental 1988;37(7):683-8.
1988: Haffner S M; Fong D; Hazuda H P; Pugh J A; Patterson J K
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.
Metabolism: clinical and experimental 1988;37(4):338-45.
1988: Knapp J A; Hazuda H P; Haffner S M; Young E A; Stern M P
A saturated fat/cholesterol avoidance scale: sex and ethnic differences in a biethnic population.
Journal of the American Dietetic Association 1988;88(2):172-7.
1988: Pugh J A; Stern M P; Haffner S M; Eifler C W; Zapata M
Excess incidence of treatment of end-stage renal disease in Mexican Americans.
American journal of epidemiology 1988;127(1):135-44.
1988: Stern M P; Haffner S M
Do anthropometric differences between Mexican Americans and non-Hispanic whites explain ethnic differences in metabolic variables?
Acta medica Scandinavica. Supplementum 1988;723():37-44.
1987: Applebaum-Bowden D; Haffner S M; Hazzard W R
The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol.
Metabolism: clinical and experimental 1987;36(10):949-52.
1987: Diehl A K; Haffner S M; Hazuda H P; Stern M P
Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones?
American journal of public health 1987;77(7):841-5.
1987: Haffner S M
Hyperinsulinemia as a possible etiology for the high prevalence of non insulin dependent diabetes in Mexican Americans.
Diabète & métabolisme 1987;13(3 Pt 2):337-44.
1987: Haffner S M; Stern M P; Hazuda H P; Pugh J; Patterson J K
Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins.
Diabetes 1987;36(1):43-51.
1986: Haffner S M; Stern M P; Hazuda H P; Pugh J A; Patterson J K
Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.
The New England journal of medicine 1986;315(4):220-4.
1986: Haffner S M; Stern M P; Hazuda H P; Rosenthal M; Knapp J A
The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins.
American journal of epidemiology 1986;123(5):830-9.
1986: Hazuda H P; Haffner S M; Stern M P; Knapp J A; Eifler C W; Rosenthal M
Employment status and women's protection against coronary heart disease. Findings from the San Antonio Heart Study.
American journal of epidemiology 1986;123(4):623-40.
1986: Stern M P; Ferrell R E; Rosenthal M; Haffner S M; Hazuda H P
Association between NIDDM, RH blood group, and haptoglobin phenotype. Results from the San Antonio Heart Study.
Diabetes 1986;35(4):387-91.
1986: Haffner S M; Stern M P; Hazuda H P; Rosenthal M; Knapp J A; Malina R M
Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites.
Diabetes care 1986;9(2):153-61.
1986: Stern M P; Haffner S M
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Arteriosclerosis (Dallas, Tex.) 1986;6(2):123-30.
1986: Hazuda H P; Comeaux P J; Stern M P; Haffner S M; Eifler C W; Rosenthal M
A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study.
American journal of epidemiology 1986;123(1):96-112.
1986: Haffner S M; Stern M P; Hazuda H P; Pugh J; Patterson J K; Malina R
Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables.
International journal of obesity 1986;10(6):493-502.
1986: Chakraborty R; Ferrell R E; Stern M P; Haffner S M; Hazuda H P; Rosenthal M
Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas.
Genetic epidemiology 1986;3(6):435-54.
1985: Haffner S M; Knapp J A; Hazuda H P; Stern M P; Young E A
Dietary intakes of macronutrients among Mexican Americans and Anglo Americans: the San Antonio heart study.
The American journal of clinical nutrition 1985;42(6):1266-75.
1985: Kushwaha R S; Haffner S M; Foster D M; Hazzard W R
Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia.
Metabolism: clinical and experimental 1985;34(11):1029-38.
1985: Knapp J A; Haffner S M; Young E A; Hazuda H P; Gardner L; Stern M P
Dietary intakes of essential nutrients among Mexican-Americans and Anglo-Americans: the San Antonio Heart Study.
The American journal of clinical nutrition 1985;42(2):307-16.
1985: Stern M P; Rosenthal M; Haffner S M
A new concept of impaired glucose tolerance. Relation to cardiovascular risk.
Arteriosclerosis (Dallas, Tex.) 1985;5(4):311-4.
1985: Haffner S M; Knapp J A; Stern M P; Hazuda H P; Rosenthal M; Franco L J
Coffee consumption, diet, and lipids.
American journal of epidemiology 1985;122(1):1-12.
1985: Franco L J; Stern M P; Rosenthal M; Haffner S M; Hazuda H P; Comeaux P J
Prevalence, detection, and control of hypertension in a biethnic community. The San Antonio Heart Study.
American journal of epidemiology 1985;121(5):684-96.
1985: Applebaum-Bowden D; Haffner S M; Wahl P W; Hoover J J; Warnick G R; Albers J J; Hazzard W R
Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol.
Arteriosclerosis (Dallas, Tex.) 1985;5(3):273-82.
1985: Haffner S M; Applebaum-Bowden D; Wahl P W; Hoover J J; Warnick G R; Albers J J; Hazzard W R
Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity.
Arteriosclerosis (Dallas, Tex.) 1985;5(2):169-77.
1985: Rosenthal M; McMahan C A; Stern M P; Eifler C W; Haffner S M; Hazuda H P; Franco L J
Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study.
Journal of chronic diseases 1985;38(1):5-16.
1984: Stern M P; Rosenthal M; Haffner S M; Hazuda H P; Franco L J
Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study.
American journal of epidemiology 1984;120(6):834-51.
1984: Hazzard W R; Kushwaha R S; Applebaum-Bowden D; Haffner S M; Steinmetz A; Foster D M
Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Metabolism: clinical and experimental 1984;33(10):873-81.
1984: Hazzard W R; Haffner S M; Kushwaha R S; Applebaum-Bowden D; Foster D M
Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
Metabolism: clinical and experimental 1984;33(9):779-84.
1984: Albers J J; Taggart H M; Applebaum-Bowden D; Haffner S; Chesnut C H; Hazzard W R
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.
Biochimica et biophysica acta 1984;795(2):293-6.
1984: Haffner S M; Rosenthal M; Hazuda H P; Stern M P; Franco L J
Evaluation of three potential screening tests for diabetes mellitus in a biethnic population.
Diabetes care 1984;7(4):347-53.
1984: Haffner S M; Foster D M; Kushwaha R S; Hazzard W R
Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin-dependent) diabetic subjects with lipaemia.
Diabetologia 1984;26(5):349-54.
1984: Applebaum-Bowden D; Haffner S M; Hartsook E; Luk K H; Albers J J; Hazzard W R
Down-regulation of the low-density lipoprotein receptor by dietary cholesterol.
The American journal of clinical nutrition 1984;39(3):360-7.
1984: Gardner L I; Stern M P; Haffner S M; Gaskill S P; Hazuda H P; Relethford J H; Eifler C W
Prevalence of diabetes in Mexican Americans. Relationship to percent of gene pool derived from native American sources.
Diabetes 1984;33(1):86-92.
1983: Hazuda H P; Stern M P; Gaskill S P; Haffner S M; Gardner L I
Ethnic differences in health knowledge and behaviors related to the prevention and treatment of coronary heart disease. The San Antonio Heart Study.
American journal of epidemiology 1983;117(6):717-28.
1983: Stern M P; Gaskill S P; Hazuda H P; Gardner L I; Haffner S M
Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study.
Diabetologia 1983;24(4):272-7.
1983: Haffner S M; Kushwaha R S; Foster D M; Applebaum-Bowden D; Hazzard W R
Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy.
Metabolism: clinical and experimental 1983;32(4):413-20.
1982: Taggart H M; Applebaum-Bowden D; Haffner S; Warnick G R; Cheung M C; Albers J J; Chestnut C H; Hazzard W R
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis.
Metabolism: clinical and experimental 1982;31(11):1147-52.
1981: Kushwaha R S; Haffner S M; Foster D M; Hazzard W R
Catabolism of alpha2-and beta-very low density lipoproteins in normal and hyperlipidemic subjects.
Transactions of the Association of American Physicians 1981;94():253-60.

Sign-in to see more